Glycoprotein hormone receptors in sea lamprey (Petromyzon marinus): Identification, characterization and implications for the evolution of the vertebrate hypothalamic-pituitary-gonadal/thyroid axes by Freamat, Mihael
University of New Hampshire
University of New Hampshire Scholars' Repository
Doctoral Dissertations Student Scholarship
Fall 2007
Glycoprotein hormone receptors in sea lamprey
(Petromyzon marinus): Identification,
characterization and implications for the evolution
of the vertebrate hypothalamic-pituitary-gonadal/
thyroid axes
Mihael Freamat
University of New Hampshire, Durham
Follow this and additional works at: https://scholars.unh.edu/dissertation
This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has
been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more
information, please contact nicole.hentz@unh.edu.
Recommended Citation
Freamat, Mihael, "Glycoprotein hormone receptors in sea lamprey (Petromyzon marinus): Identification, characterization and
implications for the evolution of the vertebrate hypothalamic-pituitary-gonadal/thyroid axes" (2007). Doctoral Dissertations. 395.
https://scholars.unh.edu/dissertation/395
GLYCOPROTEIN HORMONE RECEPTORS IN SEA 
LAMPREY (PETROMYZON MARI N il S): 
IDENTIFICATION, CHARACTERIZATION 




B.S. University of Bucharest, 1995
DISSERTATION
Submitted to the University of New Hampshire 
in Partial Fulfillment of the Requirements for the Degree of




Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
UMI Number: 3277139
INFORMATION TO USERS
The quality of this reproduction is dependent upon the quality of the copy 
submitted. Broken or indistinct print, colored or poor quality illustrations and 
photographs, print bleed-through, substandard margins, and improper 
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if unauthorized 
copyright material had to be removed, a note will indicate the deletion.
UMI
UMI Microform 3277139 
Copyright 2007 by ProQuest Information and Learning Company. 
All rights reserved. This microform edition is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest Information and Learning Company 
300 North Zeeb Road 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
This dissertation has been examined and approved.
Dissertation Director, Dr. Stacia A. Sower 
Interim Associate Dean of Research of the 
College of Life Sciences and Agriculture, 




Professor of Biochemistry and Molecular 
Biology
 ^ , / W > _____________
Dr. Clyde LMDenis,
Professor of Biochemistry and Molecular 
Biology
Dr. William A. Condon,
Professor of Animal and Nutritional Sciences
^  '  A  c --------------------
Dr. William R Moyle,
University of Medicine and Dentistry of New 
Jersey, Professor of OBGYN
c o } ~
Date
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ACKNOWLEDGEMENTS
I would like to thank:
My adviser, Dr. Stacia A Sower, for giving me the possibility to work in her 
laboratory, for her continuous support in the lab, for her suggestions and advice 
in the scientific field and in the everyday life.
Members of my Doctoral Committee: Dr. William Condon, Dr. Clyde Denis, Dr. 
William Trumble, Dr. William Moyle, Dr. Thomas Kocher for their help and 
understanding during my PhD stages.
I would like to express my gratitude to Dr. William Moyle for his generous help 
with reagents and protocols, for the insightful discussions we had and for the 
thorough comments he made on my dissertation and research in general.
All members of the Sower Lab, in particular Scott Kavanaugh for being the 
greatest colleague I ever worked with. Geoff Bushold, Matt Silver, Kazu 
Okamoto, Taka Kosugi, and many others, graduate and undergraduate students 
with whom I have shared the lab space, the reagents, the protocols, the ups and 
downs of a graduate student's life.
My wife Dana for more than I probably realize.
iii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
TABLE OF CONTENTS
ACKNOWLEDGEMENTS..............................................................................................................iii





The Vertebrate Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic-Pituitary- 
Thyroid (HPT) Endocrine Axes...............................................................................................2
Glycoprotein Hormone Receptors (GpH-R) Structure and Function.................................. 4
Evolution of Glycoprotein Hormone Receptors and Hypothalamic-Pituitary- 
Gonadal/Thyroid Axes ............................................................................................................11
The Sea Lamprey Petromyzon marinus and its Evolutionary Significance......................16
Specific A im s......................................................................................................................... 23
I. IDENTIFICATION AND CHARACTERIZATION OF THE LAMPREY GLYCOPROTEIN 
HORMONE RECEPTOR 1.......................................................................................................... 24
Introduction............................................................................................................................ 24
Materials and Methods......................................................................................................... 26
Results....................................................................................................................................34
Discussion............................................................................................................................. 38
II. IDENTIFICATION AND CHARACTERIZATION OF THE LAMPREY GLYCOPROTEIN 
HORMONE RECEPTOR II......................................................................................................... 45
Introduction  ......................................................................................................................45
iv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Materials and Methods.......................................................................................................... 47
Results....................................................................................................................................57
Discussion.............................................................................................................................. 65
III. FUNCTIONAL DIVERGENCE OF GLYCOPROTEIN HORMONE RECEPTORS.........69
Introduction............................................................................................................................ 69






APPENDIX A. IACUC Approval Note...................................................................................... 115
APPENDIX B. cAMP Assay Using the pCRE-SEAP Reporter System ................................. 116
APPENDIX C. Oligonucleotides Used in the Study of Lamprey GpH-R I and I I .................. 122
APPENDIX D. Chemical Communication in Vertebrates.........................................................123
v
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF TABLES
Table 1. Vertebrate glycoprotein hormone receptors molecular cloning............... 12
Table 2. Constitutive activity of IGpH-R 1.............................................................. 38
Table 3. Vertebrate GpH-Rs: database records, domain boundaries and IGpH-RI 
and II similarities................................................................................................... 61
Table 4. Transfection reagent amounts for pCRE-SEAP/receptor co-transfection. 
 118
Table 5. Oligonucleotides used in the study of lamprey GpH-R I and II............122
vi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
LIST OF FIGURES
Figure 1. Hypothalamic-pituitary-thyroid and hypothalamic-pituitary-gonadal axes. 
................................................................................................................................ 3
Figure 2. Diagram of a generic glycoprotein hormone receptor in complex with its 
ligand...................................................................................................................... 5
Figure 3. Glycoprotein hormone receptors signal transduction pathway.............. 8
Figure 4. Sea lamprey life cycle............................................................................17
Figure 5. Vertebrate phylogeny.............................................................................19
Figure 6. Lamprey glycoprotein hormone beta chain....................................... ...21
Figure 7. The nucleotide sequence and virtual translation of IGpH-R I CDS 33
Figure 8. IGpH-R I tissue expression pattern by RT-PCR....................................36
Figure 9. IGpH-R I cAMP functional assay.......................................................... 37
Figure 10. IGpH-R I molecular phylogeny........................................................... 39
Figure 11. Molecular cloning of lamprey GpH-R II............................................... 55
Figure 12. Lamprey GpH-R II nucleotide and protein sequences....................... 56
Figure 13. Protein fingerprints and motifs in the sequence of the lamprey GpH-R 
II........................  59
Figure 14. Exon/intron organization of the lamprey GpH-R I and II genes......... 60
Figure 15. Lamprey genomic DNA Southern blot hybridization (A) and IGpH-R II
tissue expression levels estimation by RT-PCR (B)............................................. 62
Figure 16. Hydropathy profiles of lamprey GpH-R I, II compared with mammalian 
(mouse) LH-R hydropathy....................................................................................63
Figure 17. Molecular phylogenetic analysis of glycoprotein hormone receptor 
protein sequences................................................................................................ 64
vii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 18. Preparation of chimeric receptors by Splicing by Overlap Extension 
(SOE-PCR)........................................................................................................... 74
Figure 19. Agarose gel of the products of SOE-PCR amplification......................74
Figure 20. Calculation of the SEAP initial rate......................................................78
Figure 21. Diagram of the chimeric rat LH-R/lamprey GpH-R I chimeric receptors. 
 80
Figure 22. Details of the rat LH-R/lamprey GpH-R I chimeras SSD level junctions. 
 82
Figure 23. Effect of oLH and oTSH on chimeric IGpH-R l/rLH-R receptors series 
A and B................................................................................................................. 83
Figure 24. Analysis of constitutive activity of rat LH-R/lamprey GpH-R I chimeric 
receptors series C-F.............................................................................................84
Figure 25. Response of domain-swapped rat LH-R / lamprey GpH-R I chimeras 
(series C, lamprey ED) to oLH, hFSH, hCG and PMSG...................................... 86
Figure 26. Response of domain-swapped rat LH-R / lamprey GpH-R I chimeras 
(series D, rat ED) to oLH, hFSH, hCG and PMSG...............................................87
Figure 27. Effect of SSD manipulation on the response of chimeras containing 
lamprey ED to oLH stimulation.............................................................................88
Figure B.28. Outline of the cAMP functional assay using the pCRE reporter 
system.................................................................................................................117
Figure D.29. Thyroid hormones (T3.T4) and gonadal steroid hormones...........126
viii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ABSTRACT
GLYCOPROTEIN HORMONE RECEPTORS IN SEA LAMPREY
(PETROMYZON MARINUS): IDENTIFICATION, CHARACTERIZATION AND 




University of New Hampshire, September, 2007
The vertebrate hypothalamic-pituitary-gonadal (HPG) and hypothalamic- 
pituitary-thyroid (HPT) endocrine axes involve specific interaction between 
pituitary glycoprotein hormones GpH (lutropin LH, follitropin FSH, thyrotropin 
TSH) and glycoprotein hormone receptors GpH-R (LH-R, FSH-R and TSH-R 
respectively).
GpHs and GpH-Rs originate in a common ancestral ligand/receptor pair. Their 
duplications were followed by divergent evolution resulting in the emergence of a 
novel, pituitary/peripheral gland control level. It is estimated that this occurred 
more than 500 million years ago (mya), before or concomitant with the 
divergence of the jawed vertebrates (Gnathostomes) lineage from their jawless 
(Agnathan) ancestors. This coincides with the estimated time of divergence of 
the lamprey lineage, one of the two surviving Agnathan groups (lamprey and 
hagfishes) in the actual fauna. Therefore, the study of the GpH/GpH-R system in
ix
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lamprey is of foremost importance for understanding the evolutionary 
emergence of the HPG and HPT axes. Recently, a pituitary glycoprotein similar 
with the GpH (3 chain was identified in this species.
Two glycoprotein hormone receptors (IGpH-R I and IGpH-R II of 719 and 781 
residues respectively) highly similar with Gnathostome GpH-Rs were cloned from 
sea lamprey testes and thyroid respectively. The highest tissue transcript levels 
were found by RT-PCR in testes and thyroid respectively and their exon/intron 
organization is almost identical with that of mammalian FSH-R and TSH-R. 
Mammalian LH induces a low but detectable increase in cAMP concentration in 
the cells transfected with IGpH-R I. Functional assays on lamprey GpH-R l/rat 
LH-R domain swapped chimeric receptors suggest that IGpH-R I domains 
conserved their function. Alteration of the 'hinge' or Signaling Specificity Domain 
(SSD) segment of IGpH-R I by insertion/replacement with rat corresponding 
fragments results in a drastic change in sensitivity to oLH which is also 
dependent on domain composition of the chimera.
Therefore we hypothesize that one GpH in lamprey interacts with two GpH-Rs 
in gonads and thyroid as part of a primitive HPG/T axis which antecedes the 
divergence of the Gnathostome HPG and HPT systems.
x
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INTRODUCTION
No species will survive without selective advantage that enables it to exist and 
reproduce in its environment. The observation that all complex multicellular 
organisms have gropus of differentiated cells that are separated into clusters of 
organs suggests that this type of specialization was essential for the evolution of 
most complex life forms, including vertebrates.
Specialization also appears to have been made possible by the development 
of neural and endocrine networks that enabled the function of the diverse cells in 
the organism to be coordinated. Communication between cells involves the 
release of specialized information carrier molecules (hormones), their transport to 
the target tissue (usually in blood), and recognition, binding and activation of 
specific receptors. The hormone receptors act as information transduction 
molecules allowing the metabolism of the target cells to respond to the changes 
in their environment. The hormone/receptor pairs of the endocrine systems of 
vertebrates are coupled into chains of regulatory interactions that enable the 
organism to react to internal as well as to external stimuli.
The cascade of hormonal factors of the hypothalamic-pituitary-peripheral 
gland control systems are organized into a multileveled architecture. This 
hierarchical organization of the hormonal systems is divided into 'endocrine axes' 
corresponding largely to the specific physiological compartments affected. These 
systems developed to enable neural inputs to influence endocrine processes. At 
the topmost segment, the activity of the endocrine systems is controlled by the
1
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products of secretion of the neurons in neuro-secretory nuclei located in the 
hypothalamus and pre-optic area of the brain. They are released into the 
hypothalamic-pituitary portal system and bind to their cognate receptors located 
in specific groups of cells in the anterior pituitary gland. Here they activate the 
synthetic pathways leading to production of the hypophyseal tropic hormones. 
The tropic hormones are secreted into the general circulation and reach their 
target organs and tissues. In spite of the very diverse patterns of life cycles and 
reproductive strategies and behaviors, these endocrine systems are remarkably 
conserved throughout the Gnathostome lineage [1].
In this thesis I describe two of the earliest components of the organism that 
are known to be essential to regulation of the vertebrate metabolism and 
reproduction: the Hypothalamic-Pituitary-Thyroid (HPT) and Hypothalamic- 
Pituitary-Gonadal (HPG) endocrine control axes.
The Vertebrate Hvpothalamic-Pituitarv-Gonadal (HPG) and Hypothalamic- 
Pituitarv-Thvroid (HPT) Endocrine Axes
Hormones of the hypothalamic-pituitary-gonadal (HPG) axis are involved in 
coordination of the reproductive physiology, in the development of the 
reproductive organs and in the control of the life cycles in most vertebrates. The 
pituitary tropic hormones of this axis, luteinizing hormone (LH) and follicle 
stimulating hormone (FSH), are collectively known as gonadotropins (GtH) and 
are synthesized and released into the blood stream in response to the action of a 
specific hypothalamic releasing factor (gonadotropin releasing hormone, GnRH). 
Once in the bloodstream they travel to the target organs (gonads) where they
2
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stimulate a cascade of processes which result mainly in the synthesis of steroid 
hormones. The thyroid endocrine axis is defined as the assembly of hormones 
and their anatomic-functional units implied in the regulation of the synthesis of
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Figure 1. Hypothalamic-pituitary-thyroid and hypothalamic-pituitary-gonadal axes.
Reproduced from [2].
thyroid hormones from the thyroid gland. It has a similar organization, the 
thyrotropin tropic hormone being released from anterior pituitary thyrotroph cells 
into the general circulation in response to the action of the hypothalamic 
thyrotropin releasing hormone.
The thyroid endocrine axis is responsible primarily for regulation of cellular 
energy metabolism. In different organisms, thyroid hormones are important 
factors controlling various stages of development. In amphibians for example, the 
thyroid hormone secretion is associated with the onset of metamorphosis.
The specificity of action of these two endocrine axes is in fact determined by 
the binding affinity between the glycoprotein hormones (GpH) and their
3
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receptors (GpH-R) as well as by the pattern of expression of these receptors. 
The glycoprotein hormones are dimeric proteins composed of two subunits linked 
by non-covalent interactions. In vertebrates one subunit is common in all 
glycoprotein hormones (the alpha chain) while the second subunit is distinct so it 
primarily confers specificity to the interaction with the receptor. The receptors for 
glycoprotein hormones belong to the G-Protein Couple Receptors (GPCR) 
superfamily of membrane receptors and are grouped into a distinct subfamily 
characterized by a large extracellular domain which is half of the total length of 
the mature protein. Recently a number of newly identified and characterized 
mammalian receptors have been shown to share the same general molecular 
organization with the GpH-Rs; therefore the family of proteins including the GpH- 
Rs has been extended to include these new molecules [3].
Glycoprotein Hormone Receptors (GpH-R) Structure and Function
Three types of receptors for glycoprotein hormones i.e. the gonadotropin 
receptors (follitropin receptor, FSH-R and lutropin receptor, LH/CG-R) and 
thyrotropin receptors (TSH-R) have been described in vertebrates.
After the advent of the molecular biology methods of cDNA cloning, a large 
number of glycoprotein hormone receptors have been identified. The first 
characterized were the luteinizing hormone receptors (LH-R) from pig and sheep 
ovaries [4], [5]. Most of the receptors are from mammalian species but 
glycoprotein hormone receptors have also been characterized from species of 
birds [6], [7], [8], reptiles [9], and (particularly after 2000) fish (reviewed in [10]).
4
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Moreover, glycoprotein hormone receptor-like proteins have been identified in 
invertebrates (sea anemone, Anthopleura elegantissima ([12]), the fruit fly, 
Drosophyla melanogaster [13] and the nematode Caenorhabditis elegans [13]).
Analysis of the protein sequences obtained by virtual translation from cDNA 
sequences has shown that the glycoprotein hormone receptors belong to the 
GPCR. They define a sub-family of GPCRs (glycoprotein hormone receptors, 
GpH-R) which features a large extracellular, hydrophilic N-terminal end 
accounting for half of the total length of the molecule (700 amino acid residues in 
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Figure 2. Diagram of a generic glycoprotein hormone receptor in complex with its ligand.
Modified from [11],
5
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extracellular domain has a heterogeneous organization, containing a Leu Rich 
Repeat Domain (LRD) flanked by two Cys Rich boxes [14],[15],[16], [11].
The LRD and transmembrane domains are linked by a highly divergent 
intervening segment. This region is usually termed the 'hinge' region and is 
assigned a simple, merely connective, functionality; however, there is strong 
experimental support for the concept of an important role played by this domain 
in modulation of the selectivity of the receptors towards their ligands and within 
this context the linker is termed Signal Specificity Domain (SSD, [17]).
Understanding of the tridimensional structure of the glycoprotein hormone 
receptors is limited by the difficulty in obtaining purified samples of the protein to 
be used in X-ray crystallography This is why most of the 3D information 
regarding these proteins has been been derived from structural modeling of the 
Leu Rich Repeat domain (LRD) and transmembrane domain (TMD) based on 
their homology with ribonuclease inhibitor and rhodopsin, respectively.
A tridimensional structure of the FSH receptor extracellular domain in complex 
with its ligand has been resolved and published recently ([18]).
In mammals the tissue expression of the glycoprotein hormone receptors is 
remarkably specific, with the gonadotropin receptors being expressed in gonads 
and the thyrotropin receptor being expressed in follicular cells of the thyroid. The 
specificity of expression decreases in the order FSH-R to TSH-R to LH-R. There 
have been described cases of 'ectopic' expression of LH-R and TSH-R ([19], 
[20]). However, their role in these tissues is not completely understood. It has 
also been hypothesized that transcription of the LH-R or TSH-R genes in tissues 
other than gonads or thyroid may not result in mature, functional receptors ([16]).
6
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The specificity of expression of GpH-R also decreases in early evolved 
vertebrates ([21], [22])
It is now known that glycoprotein hormone receptors interact with their 
receptors at the level of the extracellular domain ([14], [15], [11]). The details of 
the binding and signal transduction activation as well as the relative role of each 
of the extracellular domain segments in selectivity of the receptor in respect to 
different glycoprotein hormone ligands are still debated and subject to active 
investigation ([23], [17]).
In terms of receptor selectivity, there is cross binding between gonadotropins 
and their receptors which goes beyond species -- for example human chorionic 
gonadotropin (hCG) is regularly used to probe activation of the signal 
transduction pathways by novel putative gonadotropin receptors usually in 
mammalian in vitro expression systems. Moreover, there is a cross binding 
between glycoprotein hormones: the binding of human CG to human thyrotropin 
and follitropin receptors has been studied using chimeric (“yoked”) proteins 
hCG/hTSHR, hCG/hLHR, hCG/hFSHR; it has been concluded that the 
interaction between hCG and TSHR may be important in some physiological 
situations (early pregnancy) [24]. Conversely, the binding of thyrotropin hormone 
to the FSH-R has been confirmed by in vitro experiments as a possible cause for 
the effects of hypothyroidism on testicular development in humans ([25]).
7
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Figure 3. Glycoprotein hormone receptors signal transduction pathway.
The figure (reproduced from reference [15]) shows the signal transduction pathway of the 
follicle stimulating hormone receptor FSH-R.
The glycoprotein hormone receptors have been shown to act through 
activation of the cAMP dependent signal transduction pathways. The ligand 
interacts with the receptor at the level of the extracellular domain and induces the 
signal transduction through a cAMP/adenylate cyclase pathway activating the 
steroidogenesis and secretion of testosterone, estradiol or progesterone; an
8
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alternate pathway activated by hormone binding might in some circumstances be 
the PLC/IP3 signaling pathway [26].
The genes encoding the gonadotropin hormone receptors have 11 exons and 
10 introns (LH-R) or 10 exons and 9 introns (FSH-R ) ([14], [15], [11]). 
Remarkable is the fact that in vertebrates all introns are localized in the 
extracellular domain, with the only exception (so far) being the salmon 
gonadotropin receptors which have an intron in the transmembrane domain [21]). 
Analysis of the gonadotropin receptor transcripts by Northern hybridization or 
primer extension assays has detected multiple species of RNA; the possible 
mechanisms responsible for generation of these alternate transcripts include the 
existence of multiple transcription starting sites, alternate polyadenylation sites, 
and alternative splicing of the primary transcript (reviewed in [16] and [27]).
It has been suggested that the various species of alternatively spliced 
receptors have a role in modulating the activity of the full variant but this 
hypothesis has not been confirmed experimentally [28]. The systematic study of 
the regulatory regions of the gene has been done for mammalian GTH-Rs. The 
promoter responsible for the basal expression of the LH receptor in the rat has 
been identified in a region encompassed by the translation start site and position 
-173 at the 5' region of the receptor [29]. The gene lacks TATA or CCAAT 
promoter elements but in the same region there have been multiple binding sites 
identified for SP1 promoter specific transcription factors and also multiple 
putative transcription starting sites. The region between -174 and -990 may 
contain inhibitory elements that are considered responsible for the differential 
regulation of the expression of the receptor. The region beyond position -991 is
9
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also considered to contain inhibitory elements responsible for the absence of 
expression of the gene in certain cell lines [30], [31], [32].
The FSH-R gene promoter in mammals (rat and human) has been assigned to 
the region between position -1 and -286; it also lacks TATA or CCAAT elements 
and shows multiple transcription starting sites, but it doesn't contain the SP1 
binding sites found in LH-R promoters. A putative cAMP Response Element 
(CRE) has been identified in the rat FSH-R promoter but not in the human or 
mouse [15]. On the other hand, the human FSH-R promoter features a putative 
estrogen responsive element which is not present in the rat FSH-R gene 
promoter. Similar with the LH-R, the 5' region upstream of the putative promoter 
region may contain cis-acting repressor elements. Both LH-R and FSH-R in 
mammals are constitutively expressed in cell lines ( see [33] and references 
therein). All these data indicate a regulation of the GTH-R gene transcription 
which is both species and receptor specific.
In vertebrates, the functional specificity of the glycoprotein hormones, lutropin, 
follitropin and thyrotropin depends on their specific and time controlled 
expression in a few specialized tissues. Deviations from these patterns of action 
are usually associated with pathological conditions. This imposes highly 
specialized gene expression regulation mechanisms for each receptor. The 
specificity in the expression of these receptors together with the increase in the 
affinity of binding of the cognate ligand are two evolutionarily refined pathways 
towards the increase in the complexity and modularity of these endocrine axes.
The expression distribution pattern shows a sharper differentiation between 
species: in mammalian species the distribution of the expression of the
10
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glycoprotein hormone receptors seems more tissue specific than in non­
mammalian vertebrates. Although there have been reports of “ectopic” 
expression of the LH/CG receptor (e.g. in human brain [19], human sperm [34] or 
even human thyroid [35]) and of the TSH receptor (e.g. in rat fat cells [36] or 
anterior pituitary [37]) in mammals), the tissue distribution seems much more 
specific than the situation found for example in catfish for TSH-R [22] or for LH-R 
[38]. In contrast, the tissue distribution of the follicle stimulating hormone receptor 
(FSH-R) is basically restricted to the gonads in all vertebrate species [15], 
including fish [21].
Evolution of Glycoprotein Hormone Receptors and Hvpothalamic-Pituitarv- 
Gonadal/Thvroid Axes 
The Origins and Evolution of Chemical Communication.
Animal hormones have their precursors in the ancestral unicellular organisms. 
The precursors for the key signaling molecules predate the animal origins 
(reviewed in [39], [40], [41]). Also, some of the main forms of receptors have 
identifiable possible precursors in the unicellular organisms. Examples are the G- 
protein coupled receptors involved in the glucose sensitivity in yeasts ([42]) and 
the membrane receptors for insulin like factors in Tetrahymena or yeasts ([43], 
[44]). These primitive elements of chemical communication in unicellular 
organisms seem to be involved in nutrient related chemotaxis and proto-sexual 
pheromone like communication between individual cells ([45]). In the conclusive 
remarks to a comprehensive molecular phylogenetic study of the members of 
the nuclear receptor superfamily, Laudet ([46]) suggests that this class of
11
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receptors is only characteristic of Metazoans, same as the hox group of 
homeodomain proteins. However, proteins (’receptors') capable of binding 
hormone like steroid ligands (e.g. a dihydroepiandrosterone (DHEA) binding 
protein) as well as metabolic effects of steroid treatments in the ciliate 
Tetrahymena have been described ([47], [48])
The iodothyronine (thyroid hormones) roles in the regulation of basal 
metabolism might have originated in the products of iodine metabolism in 
primitive marine animals feeding on iodine-rich algae [49], [50].
Molecular Evolution of Pituitary Glycoprotein Hormones and their 
Receptors.
Table 1. Vertebrate glycoprotein hormone receptors molecular cloning.
Receptor Organism Tissue Method ID
LH-R Sus Scrofa (pig) gonads gt11 expression library screening Loosfelt 1989
LH-R Rattus rattus (rat) ovary cDNA library screening McFarland 1989
LH-R Homo sapiens (human) cDNA library screening Minegishi 1990
FSH-R Rattus rattus (rat) testis Sertoli cells cDNA library screening Sprengel 1990
FSH-R Homo sapiens (human) cDNA library screening [51]
FSH-R Homo sapiens (human) testis testis cDNA library Kelton 1992
GTH-R like Anthopleura elegantissima (sea anemone) cDNA library screening [121
FSH-R Macaca fascicularis (crab eating 
macaque)
testis RT-PCR Gromoll 1993
FSH-R Equus cabalius (horse) testis RT-PCR followed by RACE Robert 1994
LH-R Sus Scrofa (pig) testis Monoclonal antibodies raised against porcine LH 
receptor and allowed to clone the corresponding cDNA 
from testicular cells.
Misrahi 1994
FSH-R Sus Scrofa (pig) ovary RT-PCR followed by RACE Remy 1995
FSH-R Gallus gallus (chicken) ovary RT-PCR followed by RACE You 1996
LH-R Galius gallus (chicken) ovary RT-PCR followed by library screening Johnson 1996
FSH-R Ovis aries (sheep) testis RT-PCR followed by PCR screening of a cDNA library Yamey 1997
FSH-R Gallus gallus (chicken) ovary RT-PCR followed by cDNA library screening Wakabayashi 1997
LH-R Callithrix jacchus (common marmoset) testis RT-PCR followed by RACE [52]
FSH-R Equus asinus (donkey) testis RT-PCR Richard 1997
GTH-R-like (fly 
LGR1)
Drosophila melanogaster (fruit fly) cDNA library screening [13]
LH-R Gallus gallus (chicken) ovary, granulosa 
cells
cDNA library screening Mizutani 1998
GTH-R II Oncorhynchus rhodurus (amago salmon) ovarian follicles O ba1999
GTH-R 1 Oncorhynchus rhodurus (amago salmon) ovarian follicles O b a 1999
12
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Table 1 cont nued
GTH-R like (fly 
LGR2)
Drosophila melanogaster (fruit fly) RT-PCR followed by library screening [53]
FSH-R Cynops pyrrhogaster (japanese fire belly 
newt)
testis Nakayama 2000
GTH-R. partial Labeo rohita (rohu fish) PCR, genomic DNA Kumaresan 2000
GTH-R like 
(LGR)
Caenorhabditis elegans PCR [54]
LH-R Meleagris gallopavo (wild turkey) ovary RT-PCR followed by RACE [8]
FSH-R Podards sicula (lizard) ovary Borrelli 2001
FSH-R Ictalums punctatus (channel catfish) gonads RT-PCR followed by RACE [10]
LH-R Ictalums punctatus (channel catfish) gonads RT-PCR followed by RACE [10]
FSH-R Clarias gariepinus (african catfish) testis RT-PCR followed by library screening [55]
GTH-RI Oreochromis niloticus (Nile tilapia) [21]
GTH-R II Oreochromis niloticus (Nib tilapia) [21]
FSH-R Macropus eugenii (tammar walbby) ovary Mattiske 2002
G TH -R1 Danb redo (zebrafish) ovary Laan 2002
LH-R Clanas garbpinus (african catfish) gonads RT-PCR followed by library screening [22]
Recently a number of putative receptors with similar molecular organization 
have been characterized in invertebrate species as well as in mammals. This 
group of receptors, featuring a large, Leu rich repeat containing extracellular 
domain, extended the GpH-R subfamily, which is now considered as part of a 
larger group -  the LGR (Leu Rich Repeat Containing GPCR) receptors ([3]).
The glycoprotein hormone receptors have hypothetically evolved by 
duplication of a common ancestor resulted from recombination of a GPCR and 
an LRR protein [3]. One mechanism of evolutionary functional divergence of 
glycoprotein hormone receptor paralogs is the variation in protein sequence 
(coding region of the gene). The correlated change in receptor and hormone 
binding site sequences (receptor/ligand co-evolution) is one explanation 
proposed for the increased ligand binding specificity [56]. Another hypothesis is 
that the binding specificity evolved independently from signal transduction by 
introduction of domains (“negative-specificity” domains) that block inappropriate
13
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ligand-receptor interactions and decrease the affinity of binding of non cognate 
ligands [57]. The binding affinities reflect specific physiological requirements; for 
example the mouse and bovine TSH have higher intrinsic activity than human 
TSH [57]. Considerably less attention has been devoted to other mechanisms of 
evolution such as the change in tissue-specific regulation of the receptor gene 
expression [58]. It is accepted that one pathway of increasing developmental 
complexity is by partitioning the roles of the duplicated genes by changes in their 
expression regulation; for example, through differential silencing of the 
enhancers [59].
It has also been shown ([60]) that genes responsible for physiological traits 
can exhibit shifts in expression mapped to the 5' regulatory region even between 
populations of the same species. The effect of the evolutionary change in the 
regulatory pattern of a gene in a species is dependent on its position in the 
hierarchical network of regulatory interactions which control the developmental 
processes in that species ([58]).
The evolution of proteins took place through a chain of intermediates 
exhibiting small, incremental changes, associated with gradual increase in 
fitness. This minimizes the role of the blind genetic drift in evolution of protein 
functions [61].
Conserved scaffolds and active sites are crossover points for recombination 
between members of the same family of proteins resulting in new, related 
proteins with new functions [62]. The path to an increased fitness of the protein 
may go through necessary steps, some of which are in fact deleterious for the 
protein, and can be associated with down-slopes on the fitness landscape.
14
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These steps might be counterbalanced by subsequent (epistatic) changes which 
actually increase the fitness of the protein to a level higher than the one 
attainable through a regular all-rising evolutionary pathway [61].
Interacting proteins evolve at similar rates [63]. Their interaction imposes 
reciprocal structural constraints upon each other resulting in a similar rate of 
evolution between the interacting pair. Calculation of the mean difference in 
fitness effects between interacting proteins resulted in significantly lower values 
when compared with a similar set calculated for a randomized collection of 
protein pairs selected from yeast and Caenorhabditis elegans genomes [63]. This 
suggests that the similar effects on organism fitness of both members of the 
interacting pair may determine their similar evolutionary rates. However, causal 
path analysis showed that the correlation between the fitness effects explains 
only marginally the correlation between their evolutionary rates [63]. The authors 
conclude that the main factor contributing to the similar evolutionary behavior of 
the interacting proteins is not necessarily their importance for the organism but 
merely the structural constraints imposed by their interaction. This concept is 
further investigated by Hakes et al. [64] and the distinction between co-evolution 
(due to physical interaction of proteins) and correlated evolution (due to their 
functional relatedness) is explicitly stated.
A still unsolved question of molecular evolution is how the hormone receptor 
lock and key interaction models function in the context of the evolution of the 
hormone receptor complexes under a Darwinian perspective. It presumes the 
pre-existence of a key so that the receptor will evolve towards a form in which it 
best fits this interaction. The problem of the evolution of the receptor/ligand pairs
15
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or of the lock and key systems lies right at the basis of the whole evolutionary 
theory [65]. These pairs simply can not evolve. The evolutionary relationship 
between the glycoprotein hormones and their receptors is even more complex 
since both partners are capable of evolution by small changes in their sequence 
(Darwin's gradual change). Looking only at part of the picture, that is at the 
relationship between the ligands and receptor from only one major phylogenetic 
lineage, may obscure the actual path by which the receptor/ligand complexes 
have actually evolved, the 'actual path of evolution'. Evolution of two traits at the 
same time (the key and the lock, the ligand and the receptor) seems highly 
unlikely [65], [66]. Highly deleterious mutations are rescued by subsequent 
mutations which confer on the protein an advantage by inducing favorable traits, 
given the context (epistatic interactions). Evolution of a protein is subject to 
constraints that limit the paths through which the protein can reach a certain 
specialization stage [67], [61], [68].
An alternate pathway of evolutionary change of protein functional parameters 
in a physiological context is the change in the regulatory pattern of the 
expression of its gene. This is able to generate major morphological changes 
even in the absence of a radical modification of the protein sequence [58].
The Sea Lamprev Petromvzon marinus and its Evolutionary Significance
The sea lamprey Petromyzon marinus is a member of the Petromyzonidae, 
one of the only two extant jawless vertebrates in the actual fauna. The other 
agnathan representative group is the hagfishes (Myxinidae) now considered a 
sister group of lampreys(). There are 40 species of lamprey classified in three
16
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major groups. The first one, by far the most numerous includes the northern 
hemisphere lampreys (Petromyzontiformes) while the second and third groups 
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Figure 4. Sea lamprey life cycle.
Depending on their life cycle characteristics the lampreys are further classified 
as parasitic and non-parasitic. The first category includes the species in which 
one life stage includes a period when the animal attaches itself to and feeds on 
the blood and bodily fluids of other fishes. In the non-parasitic species the 
animals usually stop feeding following metamorphosis, and enter directly into the 
final reproduction stage.
Petromyzon marinus is a northern hemisphere species, and is the largest 
representative of its group and of actual jaw-less vertebrates in general. It is a 
parasitic species, with a particularly complex life cycle.
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From the fertilized eggs deposited upstream in the coastal rivers hatches an 
eyeless, primitively organized larva. The larval lampreys were so different from 
the adult that for a long period of time the larval lampreys were classified as a 
different species (ammocoetes). The larva lives in the river stream for a variable 
number of years, ranging between 3 and 7, burrowed in the river bed and filter 
feeding on the organic residues in the water. After this period (which is usually 
the longest in the lamprey life cycle) it goes through a dramatic metamorphosis to 
become a young adult. At this stage the animal migrates downstream into the 
sea where it starts its parasitic live stage which lasts for ca. 2 years. At the end of 
the parasitic phase, the reproductively mature adults migrate back up the rivers 
where they originated and where they reproduce and die [69], [70].
The phylogenetic relationship between lamprey and Gnathostomes (jawed 
vertebrates) is not yet established. The debate still persists particularly in respect 
to the monophyly or paraphyly of the lamprey and Gnathostome group. In fact, 
the problem originates in the unclear phylogenetic relationship between the 
lamprey and the hagfishes. If lamprey and hagfishes belong to the same clade as 
their morphological traits suggest, then lamprey are paraphyletic in respect to 
Gnathostome [71]. On the other hand, some molecular phylogenetic data 
indicate that lamprey are closer to jawed vertebrates than to hagfishes which 
supports the monophyletic phylogeny hypothesis of lamprey and Gnathostomes 
[72]. The latest lamprey fossil, Priscomyzon riniensis, a lamprey fossil discovered 
in 2006 in South Africa [73] shows that the body plan of the animal was 
surprisingly similar with the characteristics of the actual species. This is the 
oldest fossil found to date. It is remarkably well preserved for a type of organism
18
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Figure 5. Vertebrate phylogeny.
known not to leave many traces of its existence in the fossil deposits due to the 
lack of a mineralized skeleton. The morphology of the mouth is very similar with 
the oral apparatus of the actual parasitic lampreys, which suggests that they kept 
their adaptive features for this style of life for over 300 million years [73].
This finding classifies the lamprey as a 'living fossil1. Until then, the lamprey 
was considered a lineage which branched off the plachoderm ancestors of 
vertebrates and which lost the exoskeleton during the evolution towards a
19
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parasitic life style. It was also suggested an evolutionary scheme which changes 
the perspective on the early evolutionary events leading to divergence of 
vertebrates, the phylogeny of this animal group [73], [71].
Accordingly to the punctuated equilibrium theory, due to the low number of 
speciation events between the divergence of lamprey and the contemporary 
representatives of the lineage the modification in gene sequence was the result 
of a gradual genetic drift, with few explosive, rapidly changing mutational bursts 
associated with the speciation [74]
Understanding the hormonal control of the reproduction in Agnathans and in 
particular in the sea lamprey is of foremost importance for knowing the earliest 
events in the evolution of the vertebrates [72]. During the last few years, many of 
the lamprey hormones have been isolated and characterized ([69], [75], [76]). 
Studies done on sea lamprey reproduction have also provided evidence for the 
similarity between the neuro-endocrine control of reproduction in this Agnathan 
and the rest of the vertebrates. Two forms of gonadotropin hormone releasing 
hormone (GnRH) have been isolated from lamprey brain (lamprey GnRH-l [77], 
[78], and lamprey GnRH-lll [79]). Both GnRHs have been shown to be 
hypothalamic neurohormones controlling the pituitary-gonadal axis by extensive 
physiological, anatomical, biochemical and immunological studies [80],[81],[82]. 
A receptor for GnRH has also been isolated from sea lamprey pituitary, its 
sequence determined and the functional properties of this protein were 
investigated [83], [84]. Numerous efforts have also been directed towards 
isolation and characterization of the pituitary hormones directly controlling the 
physiology of the gonads in sea lamprey: the gonadotropin hormone homologs.
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Until recently, the experimental techniques employed proved to be elusive in 
isolating a gonadotropin-like hormone. There is substantial immunological and 
physiological evidence that supports the role of a gonadotropin-like factor in the 
lamprey pituitary. As early as 1965, Larsen showed that the effects of 
hypophysectomy on gonadal function in the river lamprey (Lampetra fluviatilis) 
are attenuated by the administration of lamprey pituitary extract or mammalian 
gonadotropin, which indicated a relationship between the physiology of the 
gonads and the pituitary hormone secretion [85]. Later it was shown that salmon 
gonadotropin injections increased the level of estradiol in the reproductively 
mature sea lamprey [86]. Immunocytochemical studies have shown 
immunoreactive GTH in the pituitary of the sea lamprey [87]. A cDNA of a 
lamprey gonadotropin has recently been cloned from the lamprey pituitary ([76]).
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Figure 6. Lamprey glycoprotein hormone beta chain
[76]. A. Identity scores of lamprey putative GTH (3 relative to selected Gnathostome gonadotropin 
hormone p subunits. B. diagram of the peptide sequence showing the relative positions of the 
signal peptide and of the 12 Cys residues in lamprey GTH p sequence. C. the degree of 
conservation of Gnathostome GTH p residues represented by the height of the vertical bars.
The specialized organs, tissues and molecules involved in the bioregulatory 
mechanisms of the ancestral organisms have left no records in the
21
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paleonthological sources. Their organization and function has to be deduced 
based on the more lasting remains of these animals and by comparison of their 
descendants in the actual fauna. This is why species like the lamprey, which 
conserve many of the characteristics of the long time extinct groups are of such 
high importance for understanding of the beginnings and the mechanisms 
leading to definition of the modern chemical control systems.
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Specific Aims
The work described here is part of a larger project which is being performed in 
the Sower Lab in the Department of Biochemistry and Molecular Biology at the 
University of New Hampshire. One of the major goals of this laboratory is to 
understand and delineate the complex neuro/endocrine axis of reproduction in 
one of the few Agnatha species remnant in the actual fauna the sea lamprey, 
Petromyzon marinus.
The work presented in this thesis addresses the pituitary/gonadal level of 
endocrine control in this species, having as goals:
1. To identify and clone the receptors for glycoprotein hormones 
from sea lamprey tissues
2. To determine their evolutionary and functional characteristics, 
relative to Gnathostome GpH-R subfamily.
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CHAPTER I
IDENTIFICATION AND CHARACTERIZATION OF THE LAMPREY 
GLYCOPROTEIN HORMONE RECEPTOR I
Introduction
Gonadotropin and thyrotropin hormone actions are mediated through a 
subfamily of G-protein coupled receptors (GPCR) namely the glycoprotein 
hormone receptors (GpH-R) [88]. Known GpH-Rs share a number of unique 
features. They are composed of two functionally distinct modules of similar size: 
an extracellular N-terminal domain followed by a prototypical GPCR segment.
The extracellular N-terminal domain is primarily responsible for high-affinity 
hormone binding and contains a central portion of nine leucine rich repeat (LRR) 
motifs, flanked by N-and C-terminal cysteine-rich clusters. The C-terminal half of 
the receptor contains a transmembrane region with the typical seven 
hydrophobic transmembrane alpha-helices, connected by intracellular and 
extracellular loops and an intracellular C-terminal domain ([14], [89], [57], [17]). 
To date, approximately 79 GpHRs have been identified and described in 36 
different species, mostly in mammals but also in three species of birds, two 
species of reptiles, one amphibian and 10 species of fish (Hovergen database, 
http://pbil.univ-lyon1.fr). There have been no GpH-Rs described in any species of 
agnathans.
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The glycoprotein hormone family consists of two gonadotropin hormones 
(GTHs), luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and 
one thyroid stimulating hormone (TSH). They are part of the cystine-knot family 
of growth factors with two non-covalently bound subunits, alpha and beta. The 
alpha subunit is common within a single species. The beta subunits are 
homologous and convey hormone specificity ([90], [11], [91]). Therefore, these 
glycoprotein hormones are believed to have evolved from a common ancestral 
molecule through duplication of beta-subunit genes and subsequent divergence 
([92], [56]). Two GTHs have been identified in all taxonomic groups of 
Gnathostomes, including actinopterygians ([93], [94]), sarcopterygians [95], and 
chondrichthyans [96], and only recently in jawless vertebrates (agnathans) [76].
Lampreys (Petromyzontidae), along with hagfish (Myxinae), are the only living 
representatives of the Agnathans, the most ancient class of vertebrates, whose 
lineage dates back over 530 million years [72]. Although the problem of the 
evolutionary relationship between these two surviving groups of Agnathans has 
not yet come to a definitive conclusion, it is well accepted that they form a 
monophyletic group to the rest of the vertebrates -  the Gnathostomes. Lamprey 
and Gnathostomes share the same jawless ancestors and this is of foremost 
importance for the contribution of the study of lamprey in understanding the 
evolutionary mechanisms which led to the definition of the functional architecture 
of endocrine control in vertebrates. This is particularly true for the pituitary 
GpH/GpH-R pairs since it is estimated that the structural and functional 
divergence of GpH-Rs coincide with the geological time of divergence of the 
Gnathostomes from their jawless ancestors.
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Lampreys, which express two forms of GnRH, lamprey GnRH-l and lamprey 
GnRH-lll [75], are important to our understanding of the reproductive success of 
the first vertebrates and are likely to have retained key characteristics of the 
ancestral GTH and GTH-R(s) from which modern GTH and GTH-Rs arose. 
Although the lamprey GnRH-l and III with a known role in the hypothalamic- 
pituitary-gonadal axis of this animal have been well demonstrated ([81], [97], 
[82]), the lamprey homologs of Gnathostome GTHs, TSHs and their receptors 
have eluded numerous attempts at identification. We report here the identification 
of a functional lamprey glycoprotein hormone receptor (IGpH-R I) similar with 
Gnathostome GTH-Rs, exhibiting its highest level of expression in the testis of 
the lamprey.
Methods and Materials
Animals. Fifty reproductively mature sea lampreys were collected from the 
Cocheco River fish ladder in Dover, NH during their upstream migration in May. 
They were transported to the Anadromous Fish and Aquatic Invertebrate 
Research (AFAIR) Laboratory of the University of New Hampshire and 
maintained under continuous flow of river water and aeration at ambient 
temperature until sampled. Sea lamprey tissue samples were collected at the 
UNH AFAIR laboratory. Approximately 100 mg tissue fragments were flash frozen 
in liquid nitrogen then kept on dry ice until stored at -80 °C.
Degenerate primers design. Degenerate primers were designed using the 
PRINTS database (http://umber.sbs.man.ac.uk/dbbrowser/PRINTSA
GLYCHORMONER protein fingerprint alignment blocks as input. The PRINTS
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database contains protein fingerprints derived by extensive statistical analysis of 
protein alignments for identification of the alignment blocks (fingerprint elements) 
which uniquely identify the corresponding protein family ([98], [99]). Selection of 
primers was based on a simple optimality score calculated using the following
formula: S=sum(Sj)/D, where S is the final optimality score for a given degenerate
primer candidate, Sj are scores assigned to each of the properties of the
individual oligos corresponding to the degenerate primer candidate and D is the 
degeneracy of the primer.
RNA isolation and degenerate PCR amplification. Total RNA of tissues was 
extracted using the TRI-Reagent (MRC) method following the manufacturer's 
protocol. Single strand cDNA was synthesized from ca. 1 pg testis total RNA 
using the AMV reverse transcriptase and the Not-I poly-A anchored reverse 
primer from Amersham (GE Healthcare, Piscataway, NJ). Amplification with 
degenerate primers (IDT, Coralville I A) was done with 1.25 U Taq Polymerase 
(Promega Corp., Madison Wl) in 25 pL reaction volume containing 200 nM dNTP,
3 mM MgC^, 0.5 pL GC-Melt (Clontech, Mountain View CA) and 0.4 pM of each
primer under the following cycling conditions: (1) 30 min initial incubation at 65 °C 
(2) initial denaturation 5 min/95 °C and (3) 40 cycles with 1 min/94 °C 
denaturation, 30 sec/65 °C annealing, 30 sec/72 °C extension. The PCR 
products were separated on NuSieve(r) low melting temperature agarose gel 
(FMC BioProducts, Rockland ME) and excision of DNA bands was followed by 
in-gel ligation into the pGEM-T Easy vector (Clontech). The ligation product was
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then used for transformation of JM109 Highly Competent cells (Clontech) which 
were plated on LB plates treated with IPTG/X-Gal for blue/white colony 
screening. Positive colonies were grown overnight in LB medium with ampicillin. 
Plasmid DNA was isolated using the Wizard(r) DNA Purification System 
(Promega) and sequenced at the Sequencing Service of the University of Utah. 
At least two samples resulting from different amplification experiments were 
sequenced for each amplicon.
RT-PCR assay. Gene specific primers derived from the transmembrane 
region of the putative lamprey GpH-R identified by degenerate PCR were used 
for a semiquantitative estimation of the expression of the corresponding genes in 
various lamprey tissues (brain, heart, intestine, kidney, liver, muscle, testes and 
thyroid) by RT-PCR. Total RNA was extracted using the TRI-Reagent (MRC, 
Cincinnati OH ) method as previously described. The amount and quality of RNA 
was estimated by optical density measurements at 260 and 280 nm in 10 mM 
Tris buffer (pH=8.0) and by non-denaturing agarose gel electrophoresis. Ten pg 
total RNA samples were incubated with 1 IU RQ1 DNase (Promega) in PCR
Buffer for 2 hours at 37 °C to remove any contaminating genomic DNA. Aliquots 
of the DNase treated total RNA were run on a non-denaturing agarose gel and 
the concentration of RNA for PCR reaction was normalized based on the relative 
intensity of the 28S ribosomal RNA bands. An alternate method for normalization 
of the total RNA amount has been employed by spotting equal volumes (1 pL) of 
the DNase treated total RNA on a agarose gel. The integrated optical density of 
each spot was calculated after background subtraction (NIH/lmageJ application) 
and the obtained values were then used for correction of the concentrations of
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the total RNA samples used as templates in RT-PCR. The one-tube 
AccessQuick(tm) RT-PCR system (Promega) was used for amplification of a 377 
bp fragment from the TM region of IGpH-R I (primers C2P6f/C2P2r). A no-reverse 
transcriptase control reaction was run for every sample. The PCR program was: 
initial denaturation 5 min/95 °C; denaturation 40 sec/94 °C, annealing 30 sec/63 
°C, extension 45 sec/72 °C for 40 cycles; final extension step 5 min at 72 °C. 
Cloning of full length IGdH-R I cDNA. Ten pg lamprey testes total RNA was
reverse transcribed at 55 °C for 1 hour with Superscript lll(r) reverse 
transcriptase (Invitrogen, Carlsbad CA) in the presence of the CDS III primer and 
SMART IV template-switch oligo (Clontech) followed by a 15 min incubation at
the same temperature in the presence of 5 mM MnCI2 to enhance the template
switch extension of cDNA. The reaction product was then treated with RNAse H 
to release the single strand cDNA from the cDNA-RNA heteroduplexes. The 5' 
end of the IGpH-R I transcript was cloned by SO-RACE while the 3' end was 
amplified using a gene specific forward primer and the CDS III primer (Clontech). 
The step-out RACE (SO-RACE) used a modified version of the two amplification 
stages protocol described in Matz et al. [100]. The PCR products which agarose 
gel migration pattern matched the one predicted from the positioning of the gene 
specific primers were isolated, cloned and sequenced as described previously. 
The 5' and 3' fragments were assembled using the pregap4 and gap4 programs 
from the Staden Package.
COS-7 expression construct Gene specific primers (IGpH-R l_TOPOf and 
IGpH-R l_TOPOr respectively) containing the START and STOP codons were
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designed and used for cloning of the full coding sequence of IGpH-R I. Briefly, 
lamprey testes total RNA was reverse transcribed with Superscript III as 
previously described and the cDNA used for PCR amplification of IGpH-R I full 
coding sequence with Phusion(tm) High-Fidelity DNA Polymerase 
(Finnzymes/NEB Ipswich, MA). The PCR product was ligated into the pcDNA(tm) 
3.1/V5-His-TOPO(r) vector (Invitrogen), cloned in TOP10 competent cells and 
checked by sequencing using vector specific sequencing primers as well as 
gene specific primers to ensure full coverage of the IGpH-R I coding sequence 
(cds). The EndoFree(r) Plasmid Maxi Kit (Qiagen, Valencia CA) was used for 
preparation of the DNA for mammalian cell transfections.
Transient expression of IGdH-R I in COS-7 cells and cAMP accumulation 
assay. COS-7 cell line was purchased from American Type Culture Collection 
(ATCC, Manassas, Virginia). Cultures were transiently transfected with IGpH-R I 
construct and with blank pcDNA3.1 vector (negative control) using Lipofectamine 
or Lipofectamine 2000 methods (Invitrogen) in 24-well plates accordingly to 
manufacturer instructions. Efficiency of transfection was estimated by control 
transfections with pcDNA3.1A/5-His-LacZ vector followed by Beta-Gal staining 
(Invitrogen). The putative lamprey native ligand for this receptor was not 
available at the time of these experiments so human chorionic gonadotropin 
(hCG, Sigma-Aldrich, St.Louis MO) was used instead for stimulation of 
transfected COS-7 cells. Intracellular accumulation of cAMP was estimated after 
3 hours incubation with various concentrations of hCG in Krebs-Ringer buffer 
containing 0.1% pyrogen free BSA (Calbiochem) and 0.1 mM IBMX (Sigma). The 
buffer was aspirated, cells lysed in 0.1 M HCI or in an Amersham proprietary lysis
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reagent and the concentration of cAMP measured by RIA. The 1-125 cAMP tracer 
and cAMP antiserum were a generous gift from Dr. William Moyle (University of 
Medicine and Dentistry of New Jersey). Results are expressed as fold increase 
over the basal level of intracellular cAMP +/- SEM versus the concentration of 
hCG in the stimulation medium.
Effect of IGdH-R on basal levels of intracellular cAMP. To estimate the effect 
of IGpH-R I on the basal production of cAMP in transiently transfected COS-7 
cells a secreted alkaline phosphatase (SEAP) based reporter system was used. 
It showed a higher sensitivity compared to the RIA procedure in experiments 
where the rat LH-R was stimulated with hCG or ovine LH (data not shown). The 
reporter plasmid pCRE-SEAP contains three cAMP Responsive Elements (CRE) 
upstream from the gene encoding a modified human placental alkaline 
phosphatase which is secreted into the culture medium upon stimulation by 
intracellular cAMP. COS-7 cells were co-transfected with various amounts of 
pcDNA3.1/IGpH-R I or empty pcDNA3.1 (0.05, 0.1, 0.2, 0.4, 0.6 and 0.8 pg) and 
0.8 pg pCRE-SEAP or pTAL-SEAP (negative control) in 24 well plates with 2 pL 
Lipofectamine 2000 transfection reagent (Invitrogen) following the manufacturer's 
protocol. After 24 hours incubation, the culture medium was aspirated and 
replaced with low serum OptiMEM medium and incubated overnight. The next 
day the medium was replaced with serum and phenol red free DMEM (HyClone) 
containing 0.1% BSA (Calbiochem) with or without 0.1 mM IBMX. A third 
treatment consisted in 0.1%BSA, 0.1 mM IBMX and 5 pM forskolin DMEM for 
each IGpH-R I vector amount for normalization of the transfection efficiencies. 
After 18 hours of incubation, the medium was collected, centrifuged for 10 min at
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10OOOg at 4 °C then heated at 65 °C for 30 min to eliminate the intrinsic alkaline 
phosphatase activity. A 20 pL aliquot of each sample was then mixed with 
reaction buffer (50 mM Tris, pH=8.2) containing 28 mM pNPP (para-nitrophenyl 
phosphate) alkaline phosphatase chromogenic substrate then incubated at 37
°C. The optical density was read at 405 nm on a microplate autoreader (BioTek) 
at approximately 3 hour time intervals. The results reported here are derived from 
end-point optical density measurement data obtained after approximately 24 
hours incubation. Absorbance in each well was corrected by subtraction of the 
pTAL-SEAP corresponding measurement and normalized in respect to the 
corresponding response to forskolin treatment. The same procedural outline was 
applied for analysis of the effect of different glycoprotein hormone treatments 
(hCG, ovine LH and ovine TSH) on activation of cAMP mediated signal 
transduction by IGpH-R I.
Software applications. Assembling of sequencing readings was done with the 
pregap4 and gap4 programs from the Staden Package [101]. Sequence 
alignments were done using the Clustalw [102] method. The signal peptide 
cleavage site was predicted using the SignalP [103] program 
(http://www.cbs.dtu.dk/services/SianalP/). Transmembrane regions were 
characterized from the thermodynamic profile of the region with programs from 
EMBOSS package (octanol), the GPCR specific Prosite [104] signature was also 
identified using the Prosite motif finder from EMBOSS package (patmatmotifs) 
with a locally installed copy of the Prosite database.
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Figure 7. The nucleotide sequence and virtual translation of IGpH*R I CDS.
The signal peptide is underlined. Transmembrane regions are shaded and labeled accordingly at 
their N-terminal border; putative glycosylation motifs are marked by rounded corner boxes, the 
protein kinase putative phosphorylation sites are marked by shaded ellipses. Specific residues 
and motifs mentioned in text are encircled and labeled.
For identification of protein motifs and patterns the Prosite and InterPro [105] 
search services were used with the IGpH-R I amino acid sequence as query. The 
maximum parsimony algorithm as implemented in the protpars application of the 
PHYLIP package [106] version 3.6 was applied to 1000 bootstrap replica
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(seqboot, PHYLIP package) of the initial amino acid sequence, then the 
consensus tree was derived using the consense program from the same 
package.
Analysis of the RT-PCR gel images was done with ImageJ application from 
NIH [107]. Functional data analysis and graphing were done in Prism (GraphPad, 
San Diego CA).
Results
Five distinct primer pairs: GHRS1_128f/GHRS7_512r, GHRS2_256f
/GHRS8_512r, GHRS2_256f/GHRS7_512r, GHRS2_256f/GHRS3_144r,
GHRS7_512f/GHRS8_512r (see Table 5) amplified DNA fragments with sizes 
varying between 150 and 800 bp highly similar with Gnathostome GpH-Rs. The 
sequencing readings were assembled in gap4 (Staden package) and the 
resulting contig approximately 800 bp has been named lamprey glycoprotein 
hormone receptor I (IGpH-R I). A smaller number of readings were assembled 
into a second, distinct contig which we consider a fragment of a second 
glycoprotein hormone receptor (IGpH-R II).
Combination of 3' and 5' RACE reactions resulted in a set of overlapping DNA 
clones. The assembled contig was 2705 bp in length. This included a 504 bp 5' 
untranslated region featuring two possible translation start sites, an open reading 
frame of 2157 bp and a 3' untranslated fragment of 44 bp containing two putative 
polyadenylation signals. The most likely translation start site was assigned based 
on comparison of the virtual translation of the full transcript with the protein 
sequences of GpH-R homologs. Total length of the predicted protein is 719
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amino-acid residues. The first 29 C-terminal amino-acid residues correspond to 
the putative signal peptide predicted by the SignalP program and confirmed by 
comparison with other homologous receptors. The extracellular domain including 
the signal peptide is 350 amino-acid residues. A 264 residue transmembrane 
domain is followed by a putative cytoplasmic tail of 105 residues.
Structural domains of the IGpH-R I were identified based on detection of 
specific patterns and motifs and their limits were established relative to the 
alignment of the protein sequence with other vertebrate GpH-Rs (Figure 7). 
IGpH-R I shows the typical structural domain composition of the Gnathostome 
GTH- and TSH-Rs: extracellular domain, rhodopsin-like transmembrane domain 
and cytoplasmic domain. In the extracellular domain of the IGpH-R I were also 
identified a Cysteine Rich N-terminal domain followed by a Leucine Rich Repeat 
(LRR) containing region and a C-terminal Cys Rich Region.
Putative N-glycosylation sites in positions 86, 207, and 285 in the extracellular 
domain and one putative N-glycosylation site has been predicted at position 651 
in the cytoplasmic of the receptor. Seven hydrophobic helical segments (Figure 
7, TM1 to TM7) circa 20 residues in length are linked by 3 intracellular (IL) and 3 
extracellular (EL) loops. A disulfide bridge between Cys residues located in EL1 
and EL2 is also important for stabilization of the receptor conformation. The C- 
terminal end of the 3rd transmembrane helix harbors a protein motif shared by all 
members of the GPCR superfamily. The cysteine residue in position 630 matches 
the well conserved Cys residue shown to be palmitoylated and anchored to the 
cell membrane in the rest of the members of the GpH-R family.
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Figure 8. IGpH-R I tissue expression pattern by RT-PCR.
Total RNA samples were DNAse treated then their concentration normalized relative to either 
28S ribosomal RNA or total RNA amount. RNA samples were amplified in one-tube RT-PCR 
experiments in parallel with no-reverse transcriptase controls. The graph shows results from at 
least three experiments with total RNA extracted from different animals. The Y-axis is scaled in 
arbitrary units representing the ratio of each tissue RT-PCR signal to the RT-PCR signal of testis 
sample obtained in the same experimental run.
Globally the IGpH-R I has a high sequence identity with Gnathostome 
receptors as calculated based on the Clustalw alignment of 46 GpH-R amino- 
acid sequence with the virtual translation of IGpHR I coding sequence. The 
lowest identity was found for salmon TSH-R (as low as 7% identity) compared to 
the highest calculated for canine TSH-R (50% identity). With the exception of 
salmon TSH-R the identity varies between 44% (salmon LH-R) and 50% (dog 
TSH-R) showing the higher values for TSH- and FSH-Rs. Comparison of IGpH-R 
I with fish receptors resulted in the lowest identity values for all GpH-Rs.
Forty nine vertebrate GpH-R protein sequences were used for reconstruction 
of the molecular phylogenetic relationships within this class of proteins, using the 
GpH-R isolated from sea anemone (Anthopleura elegantissima) [12] as an 
outgroup. The resulting tree has the usual topology of the phylogenetic trees
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most often reported for this family of proteins, with two major clades mirroring the 
functional distinction between the TSH-Rs and GTH-Rs. IGpH-R I and the GTH- 
Rs form a monophyletic group, the lamprey receptor being the earliest diverged 
member of this clade.
The highest level of the receptor transcript was identified in the lamprey testis 
tissue using RT-PCR. Detectable levels of the receptor transcript were also 
shown in brain, heart, intestine, kidney, liver, muscle and thyroid as depicted in 
Figure 8. This figure shows the relative levels of the IGpH-R I signal in different 
tissues calculated as percent of the RT-PCR signal found in the testis samples.
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Figure 9. IGpH-R I cAMP functional assay.
(A) cAMP accumulation in response to hCG stimulation of COS-7 cells transiently 
transfected with a pcDNA3.1/V5/His expression construct of IGpH-R I. On Y-axis the fold 
increase in intraceilular concentration of cAMP relative to the basal level. On X-axis the 
concentration of hormone in the stimulation medium (lU/mL). (B) Comparison of activation of 
SEAP reporter gene activation following the treatment of COS-7 transiently transfected cells 
with IBMX, hCG, oLH and oTSH. The values on the Y-axis represent the ratio (fold increase) 
between the results obtained for IGpH-R I and pcDNA3.1 transfected cells, after 
normalization in respect to the response to the treatment with 5 pM forskolin.
Incubation of COS-7 cells with increasing amounts of human chorionic 
gonadotropin (hCG) induced an increase in levels of intracellular cAMP amounts 
determined by RIA. However the differences over the basal level was slight
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Figure 9A). Indirect estimation of cAMP synthesis induced by increasing amounts 
of IGpH-R I transfected into COS-7 cells showed an increase in the basal level of 
cAMP with the amount of IGpH-R I plasmid (Table 2) suggesting that the lamprey 
receptor may constitutively induce activation of the cAMP signaling at least in a 
mammalian cell line.
Table 2. Constitutive activity of IGpH-R I.
Plasmid amount (fig)
0.05 1.0 2.0 1.0 6.0 8.0
IG p H -R  I basal c A M P -b
No IB M X 0 .1 3 0.11 0 .1 6 0 .2 0 .2 4 0 .2 7
IB M X  0 .2  m M 0 .2 2 0 .1 9 0 .2 3 0 .2 6 0 .2 9 0 .3 2
pcD N A 3 .1  basa l c A M P
No IB M X 0 .1 3 0 .1 2 0 .1 3 0 .1 3 0 .1 4 0 .1 4
IB M X  0 .2  m M 0 .2 6 0 .2 3 0 .2 2 0 .2 0 0 .2 2 0 .2 3
Comparison between the abilities of different glycoprotein hormones to induce 
the cAMP dependent secretion of the reporter protein in the medium showed a 
higher response for mammalian (ovine) LH and TSH compared to chorionic 
gonadotropin.
Discussion
The deduced protein sequence of a 719 amino-acid GpH-R (IGpH-R I) was 
determined from a 2705 bp cDNA clone isolated from the testes tissue of one of 
the most ancient vertebrate species, the sea lamprey. The key motifs, sequence 
comparisons and characteristics of the identified GpH-Rs reveals a mosaic of 
features common to all other classes of GpH-Rs in vertebrates. The lamprey 
GpH-R I was shown to activate cAMP in response to treatment with mammalian 
glycoprotein hormones of transiently transfected COS-7 cells.
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Figure 10. IGpH-R I molecular phylogeny.
Representation of the molecular phylogenetic relationships between members of the 
glycoprotein hormone receptor protein family. This is a consensus tree derived from maximum 
parsimony trees calculated for 1000 bootstrap replica of an original set of 49 protein sequences 
of vertebrate and invertebrate (sea anemone, Anthopieura elegantissima) GpH-Rs. Branches 
with bootstrap scores lower than 950 are labeled with the corresponding values.
The highest expression of the receptor transcript was demonstrated in the 
lamprey testes using RT-PCR. Expression of the receptor transcript was also 
shown in lower amounts in brain, heart, intestine, kidney, liver, muscle and
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thyroid. The high expression of IGpH-R I in the testis and the high similarity with 
Gnathostome GTH-Rs suggest that IGpH-R I functions as a receptor for lamprey 
GTH.
The total length of IGpH-R I (719 aa) is intermediary between the lengths of 
the GTH- and TSH-Rs from Gnathostomes (695 and 750 in average) ([10], [21]). 
The differences are due in most part to the differences in the number of residues 
in the ectodomain and cytoplasmic domain compared to the other GpH-Rs. 
IGpH-R I has the shortest extracellular domain (estimated at 320 residues 
without the signal peptide) compared to around 350 residues in GTH-Rs and 
around 400 in TSH-Rs. Its cytoplasmic domain is correspondingly the longest in 
the family (estimated at 106 residues, compared to around 80 in TSH-Rs, 70 in 
LH-Rs and only 60 in FSH-Rs).
The N-terminal half of IGpH-R I has the lowest identity with the vertebrate 
GpH-Rs. Potential functionally important residues at different sites in the 
extracellular domain of IGpH-R I are unique to this receptor in the context of the 
conservation of the global domain organization. This might be of particular 
significance for understanding the functional divergence of this class of 
receptors. The region is important for ligand binding and contains the 
determinants of the specificity of binding of agonists to the GpH-Rs ([89], [88], 
[108], [57]).
The Arg in position 192 in IGpH-R I (Figure 7, (i)) corresponds to a well 
conserved Lys residue in TSH-R and LH-R. It has been shown that mutation of 
the human TSH-R Lys residue in this position to Arg abolishes the ligand 
specificity of the receptor leading to increased sensitivity of the human TSH-R to
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chorionic gonadotropin (hCG) ([14], [27]). Two other interesting residues are the 
Lys and Asp residues in position 89 and 91 respectively of the IGpH-R I, located 
downstream of a glycosylation site which IGpH-R I shares with TSH-Rs (Figure 7, 
(ii)). They correspond to Arg and Tyr residues in the TSH-R consensus (positions 
80 and 82 respectively in rat TSH-R). It has been shown [109] that concomitant 
mutations Arg80Lys + Tyr82Glu results in a gain of sensitivity of TSH-R to hCG.
The rat LH-R LeuXxxCysXxxGly motif close to exon 1 to 2 junction shown to 
be crucial for LH/hCG hormone binding [110] matches the IGpHR I 
ValXxxCysXxxGly residues and is distinct from the TSH-R consensus in the 
same position. Ala substitution of any of these residues resulted in no hormone 
binding although the receptor was successfully expressed on the cell membrane.
Costagliola etal. [111] described a specific motif in TSH-R downstream of the 
C-terminal Cys rich domain. The motif with consensus sequence YDY is the site 
for sulfation at one of the tyrosine residues and located upstream at the start of 
the transmembrane domain. Its presence has been shown to be a requirement 
for binding and activation of TSH-R and is suggested to play a similar role in 
GTH-Rs. The motif is very well conserved in TSH-Rs, common in mammalian 
LH-Rs and present only sporadically in FSH-Rs (where the consensus FDY can 
be found instead). This motif is missing in IGpH-R I which is another element 
differentiating the IGpH-R I from vertebrate TSH-Rs in apparent contradiction with 
the global similarity results.
The glycosylation of the extracellular domain of GpH-Rs has been shown to 
be important for the function of these receptors [14]. The presence of only 3 
glycosylation sites in the extracellular domain differentiates the lamprey receptor
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from all other known GpHs which have 6 (TSH-R and LH-R) or 5 (FSH-R) such 
motifs in this domain. However, the glycosylation motif in position 86 aligns with a 
similar motif in TSH-Rs, the one in position 207 is common to all GpH-Rs while 
the NLT glycosylation motif at the N terminal end of the C-terminal Cys Rich 
Domain is common in most FSH-Rs.
Tissue expression pattern and functional assay. Initially the receptors for 
GpHs seemed to be characterized by their high tissue expression specificity 
([14], [89]) in accordance with their tissue specific physiological roles [3]. Later, a 
couple of examples of “ectopic” expression of these receptors in mammals have 
been described by various authors ([34], [36]). It has become accepted that LH- 
Rs are more prone to show extragonadal expression and are less specific while 
the FSH-R and TSH-R genes are under a more stringent control over their tissue 
expression and binding specificity. Identification and cloning of the GTH- and 
TSH-R homologs in fish species seemed to confirm this paradigm, although the 
diversity of tissues where the transcripts of GpH-Rs, in particular of fish LH-Rs 
could be detected has increased ([55], [10], [38], [112]). The low specificity in 
tissue expression of lamprey GpH-R I seems to confirm an evolutionary trend of 
decreased stringency of gene expression control in ancient vertebrate lineages. 
Nevertheless, its highest level of expression in the testicular tissue of the male 
lamprey supports the hypothesis of the involvement of IGpH-RI in the endocrine 
control of the reproduction in lamprey in completion of a hypothalamic-pituitary- 
gonadal axis as known for all jawed vertebrates ([14], [89]).
Conclusion. Evolution of glycoprotein hormone receptors. Overall, analysis of 
the primary structural features of the lamprey GpH-R I reveals characteristics
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which support the hypothesis of its homology with Gnathostome GTH- and TSH- 
Rs. On the other hand it does not offer strong support for its classification in 
either of these two groups. The vertebrate GpH-Rs have been divided into two 
subclasses based primarily on the functional criterion of implication in two distinct 
endocrine control axes in Gnathostomes. It has been speculated that the GpH-R 
evolved from possibly ligandless GpH-Rs, whose function was accomplished by 
(non hormonal) regulation of their constitutive activity. The increased specificity of 
the receptors in later evolved vertebrates seems associated with the decrease in 
their constitutive activity in the context of correlated mutations in receptor and 
ligand leading to increased thermodynamic stability of the complex [27]. 
Identification of new orphan receptor members of the GpH-R family (LGR) in rat 
and human showing a very low tissue expression specificity and high constitutive 
activity seems to confirm this scenario ([3], [113]).
The lamprey GpH-R I described in this paper is the first receptor for 
glycoprotein hormones described in Agnathans. It is highly similar and the key 
motifs present in its sequence suggest that it is likely a homolog of the vertebrate 
gonadotropin and thyrotropin receptors. However, it does not lend itself to a 
formal classification in one of these two Gnathostome GpH-R groups. Its 
detectable response to a mammalian gonadotropin indicates that it is a functional 
receptor that has a role in sea lamprey reproductive physiology. To date there 
has been no evidence to support the presence of TSH in this species and only 
one GTH-like hormone has been identified [76]. It has been previously shown 
that treatment with salmon gonadotropin extract induces an increase not only in 
plasma estradiol concentrations but also in plasma thyroxine concentrations in
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male and female adult sea lampreys [114]. Based on these results it has been 
hypothesized [76] that the thyroid and the gonads of the lamprey are under a 
pituitary control mediated by the same glycoprotein hormone. From this 
perspective the endocrine physiology of lamprey antecedes the evolution of the 
pituitary-gonadal and pituitary-thyroid axes in Gnathostomes (jawed vertebrates). 
However, further investigations are required for characterization of the ligand 
binding and signal transduction activities.
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CHAPTER II
IDENTIFICATION AND CHARACTERIZATION OF THE LAMPREY 
GLYCOPROTEIN HORMONE RECEPTOR II
Introduction
The search for the origins of the hypothalamic/pituitary/peripheral gland 
endocrine systems in the closest relatives of vertebrates, the protochordates 
([115], [116], [117], [118], [119], [120]) has provided proofs for the existence of 
some of the components of the HPG and/or HPT axes in Amphioxus and/or 
Ciona. However, there is limited evidence at this point for their assembling into 
functional HPG/HPT axes in these organisms. A brain-Hatschek's pit connection 
has been described in amphioxus [121]. However, the hypothalamic-pituitary- 
peripheral gland systems and in this context the differentiation between control 
mechanisms of thyroid hormone and steroid (gonadal) hormone levels is 
considered to be a vertebrate innovation which emerged prior to or during the 
differentiation of the ancestral Agnathans into the two main groups of vertebrates 
in the actual fauna: the Cyclostomes (lamprey and hagfishes) and 
Gnathostomes.
New paleonthological evidence traces the lamprey lineage down to the base 
of the phylogenetic tree of vertebrates ([73], [71]). Formerly considered a 
'degenerate' branch of the ancestors of vertebrates, the ostrachoderms [71], the 
discovery of the fossil remains of an organism surprisingly similar with the
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lamprey but dating 360 mya back in the late Devonian indicates that the 
contemporary cyclostomes diverged from the ancient Agnathans much earlier 
than usually considered. This discovery places this species in the 'living fossil' 
group and cast a new significance over the results obtained from the study of this 
organism.
During the last few years, many of the lamprey hormones have been isolated 
and characterized ([69], [122]). Studies done on sea lamprey reproduction have 
also provided evidence for the similarity between the neuro-endocrine control of 
reproductive physiology in this Agnathan and the rest of the vertebrates. Two 
forms of gonadotropin hormone releasing hormone (GnRH) have been isolated 
from lamprey brain (lamprey GnRH-l [77], and lamprey GnRH-lll [79]). Both 
lamprey GnRH decapeptides have been shown by extensive physiological, 
anatomical, biochemical and immunological studies ([123], [81], [82], [80]) 
capable of controlling the reproduction in lamprey and involved also in regulation 
of the thyroid hormone levels in plasma. A receptor for lamprey GnRH has been 
isolated from the sea lamprey pituitary, its sequence determined and the 
functional properties of this protein were recently published [83]. In addition, 
numerous efforts have been directed towards isolation and characterization of 
the pituitary hormones directly controlling the physiology of the gonads in sea 
lamprey: the gonadotropin hormone homologs. These efforts led to the 
identification of a pituitary glycoprotein similar in sequence with the beta chain of 
the Gnathostome glycoprotein hormones [76]. Analysis of the molecular 
phylogenetic data suggests that this molecule is probably an ortholog of the 
common molecular ancestor of beta LH, FSH and TSH and diverged from its
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Gnathostome counterpart before differentiation of the different types of beta 
GpH-Rs [76]. The functional characteristics of this protein and its role in the 
physiology of lamprey in relationship with the well established HPG/T axes 
paradigm is currently being investigated.
The molecular cloning attempts to identify the lamprey glycoprotein hormone 
receptors resulted in identification, cloning and characterization of a lamprey 
member of the GpH-R subfamily (IGpH-R I) [124]. This protein was found 
expressed predominantly in the gonadal (testicular) tissue of the mature lamprey. 
Its sequence has a number of features which are characteristic of the 
gonadotropin receptors. It was shown to have low albeit detectable response to 
mammalian gonadotropin hormones but no response to mammalian thyrotropin. 
Incidental data obtained during identification of the lamprey GpH-R I suggested 
the existence of a second receptor from the same protein family in this animal. 
This paper reports the identification in the testes tissue, cloning of the full coding 
sequence from the thyroid tissue and characterization of a second sea lamprey 
glycoprotein hormone receptor (IGpH-R II, GenBank AY750689) similar to 
Gnathostome gonadotropin and thyrotropin receptors.
Materials and Methods
Animals and tissue sampling. The reproductively mature, migrating sea 
lampreys were collected during their seasonal migration upstream in the 
Cocheco river in Dover, NH. They were transported to the UNH AFAIR 
(Anadromous Fish and Aquatic Invertebrate Research) Laboratory where they
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were kept under a continuous flow of river water at ambient temperature in a 
large tank until the time of the experiments.
Animals were killed by decapitation and the tissue samples were immediately 
collected, flash-frozen in liquid nitrogen and kept on dry ice until their storage at 
-80 °C. The sea lamprey does not have a clearly separated thyroid gland. 
Thyroid hormones are secreted from a number of secretory follicles scattered in 
the conjunctive tissue located on top of the inferior jugular vein, underneath the 
gill basket of the animal [125]. The conjunctive tissue located on the dorsal side 
of the jugular vein between gills number 2 and 6 was collected and used for the 
preparation of the total RNA used for IGpH-R II cloning and RT-PCR 
experiments. The following tissues were also collected and used for 
determination of tissue specific expression levels by RT-PCR: testes, liver, 
muscle, intestine, kidney, thyroid and brain.
Total RNA extraction and preparation of single strand cDNA. Extraction for 
preparation of the total RNA used for cloning the IGpH-R I is described in [124]. 
Extraction of total RNA for cloning (SO-RACE and full CDS amplification) of 
IGpH-R II used lamprey thyroid tissue. The protocol followed the general 
guidelines in the Tri-Reagent (MRC) user manual, with a couple of differences. 
Briefly, the tissue was removed from the -80 °C freezer and kept on dry ice until 
homogenization. Approximately 100 mg of tissue was used for total RNA 
extraction. One mL TRI-Reagent was transferred to a glass homogenizer, the 
tissue was added to the extraction reagent and immediately homogenized. 
Extraction of total RNA for RT-PCR followed the same protocol as used for total 
RNA extraction for RACE. The extracted total RNA was run on a non-denaturing
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agarose gel to asses the quality and relative amount of RNA. The integrated 
optical density of the RNA signal on gel was calculated using the ImageJ 
scientific image manipulation Java application from NCBI [107], The low 
molecular, likely degraded RNA signal on gel was ignored in normalization of the 
total RNA amounts used for RT-PCR. The absolute concentration of RNA was 
estimated for the sample with the highest quality of RNA as assessed from gel. 
RNA sample dilutions were corrected to approximately 200 ng/ pL for all tissues. 
Total RNA extracted from testis tissue was used for preparation of the single 
strand complementary DNA using a polyA anchored primer containing a Not I 
recognition site at the 5' end (Amersham) using the reagents and the protocol 
provided by the single strand cDNA synthesis kit from Amersham. Preparation of 
ss cDNA for SO-RACE: The single strand cDNA was synthesized using the 
Superscript III (Invitrogen) or PowerScript (Clontech) reverse transcriptase. 
Multiple samples were prepared at different incubation temperatures, using 
Clontech CDSIII universal primer or a reverse gene specific primer for reverse 
transcription. cDNA substrate was mixed with the reverse primer and SMART IV 
oligo, denatured at 65 °C for 10min then immediately chilled on ice. After addition 
of the reaction cocktail containing the reverse transcriptase in the appropriate 
buffer, dNTP and DTT accordingly to the manufacturers' instructions, tubes were
incubated at 42 °C or 52 °C for 1 hour then heated 15 min at 70 °C in order to 
denature the enzymes. The resulting cDNA product was then treated with 2 III of 
RNAse H for 20 min at 37 °C to release the single strand cDNA from the 
DNA/RNA heteroduplexes.
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PRINTS/GLYCHORMONER fingerprint based degenerate primers and
identification of glycoprotein hormone receptor transcripts. The methodology 
used for the design and testing of the degenerate primers for detection of 
glycoprotein hormone receptors was described previously (Chapter I, [124]). 
Briefly, primers were designed based on the GLYCHORMONER glycoprotein 
hormone receptor fingerprint from PRINTS database. Each alignment block of 
the fingerprint was translated into a degenerate nucleotide sequence then the 
least degenerate 32-mer primer candidates were selected for each element 
(degeneracy level ranging between 80 and 2000). The non-degenerate oligos 
corresponding to each degenerate primer candidate were generated and a PCR 
optimality score was calculated for each of them. A global optimality score for 
each degenerate primer candidate was then derived as a weighted average of 
the scores of the corresponding non-degenerate oligos. Every 10th non­
degenerate oligo was also tested by BLAST local alignment against the GenBank 
nucleotide database. The final primers were ranked based on both their predicted 
amplification efficiency score and BLAST scores. Calculations were done using 
peri scripts coupled with applications from EMBOSS package and the blastcl3 
NCBI BLAST client. Around 10 combinations of forward/reverse primers were 
used for amplification of lamprey testes cDNA. Resulting PCR clones were 
ligated in pGEM-T Easy vector, transformed into JM109 cells, plasmid DNA 
extracted with Wizard DNA preparation system (Promega) and sent out for 
sequencing.
Screening the sea lamprey whole genome sequencing trace repository. A 
lamprey whole genome sequencing project was recently started and the primary
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sequencing data (trace files and base calls) were made available to the scientific 
community in TraceDB section of NCBI. The fasta formatted base calls from the 
sea lamprey whole genome sequencing project were downloaded from NCBI 
trace repository (http://www.ncbi.nlm.nih.aov/Traces/trace.cai) and indexed for 
Blast search on the iNquiry bioinformatics server of the University of New 
Hampshire. The traces database was then screened for the GpH-R similar 
clones using the 'mpiblastn' program with full CDS or fragments of the lamprey 
GpH-R I. Blast hits with a similarity score lower than 90% were then used for 
screening the public NCBI nucleotide databases using translating blast (tblastx) 
for identification of the possible protein similarities.
Amplification of 5' end of IGdH-R II bv Step-Out RACE. The universal primers 
5proxB and Udist for amplification of 5' end of IGpH-R II by SO-RACE are 
described in [100]. They are complementary with the SMART IV oligo sold by 
Clontech so these primers were custom synthesized and used with the SMART 
IV from the cDNA library construction kit from Clontech. The Step-Out RACE was 
a slightly modified version of the protocol described in [100]. Briefly, the single 
stranded cDNA was diluted 1/10 then amplified with the 5proxB primer and the 
downstream reverse primer. The product of reaction was checked after 30 cycles 
by running a 4 pL aliquot of the reaction on an agarose gel. If only a faint smear 
was observed the reaction was stopped there otherwise 5 more cycles were run 
to bring the total number of cycles to 35. A 1/20 dilution of these first stage 
reactions was used as templates in the second step of the procedure, consisting 
of amplification of the DNA product of 1st step with the Udist universal primer and 
an upstream (nested) 3' gene specific primer. The number of cycles in the
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second amplification step was 20 with 5 more cycles run if no signal was 
observed on the gel (25 cycles maximum). DNA clone samples for sequencing 
were submitted at the DNA Sequencing Center of the University of Utah or to 
SeqWright (Texas) where they were sequenced using the Big Dye terminator 
method. The DNA fragments were preprocessed with pregap4 and then 
assembled with the gap4 sequence assembler from the Staden package.
Estimation of tissue expression level of IGpH-R II bv RT-PCR. The one-tube 
RT-PCR system AccessQuick RT-PCR system from Promega was used 
according to the manufacturers instructions. The tissue specific total RNA 
template was normalized in respect to the total amount of RNA as described 
previously [124]. The gene specific primers were designed based on the 
sequences of the PCR clones corresponding to the transmembrane domains. 
Negative control (no reverse transcriptase) RT-PCR reactions were run for each 
sample to prevent the artifacts resulting from amplification of genomic DNA.
Detection of GdH-R in lamprey genomic DNA. A 456 bp DIG labeled DNA 
probe was generated by amplification of a fragment of lamprey GpH-R I with 
gene specific primers designed against the transmembrane domain of the 
receptor (forward primer TCTGCAGGAGGCTCTTCAACAACAAG, reverse primer 
TCAGGATGACGAGGATGACGATGG) in the presence of DIG-dUTP:dNTP 
nucleotide mix using the DNA labeling PCR kit from Roche, following the 
manufacturer's instructions. The labeling efficiency was estimated by comparing 
the size of the amplified products with the size of the DNA fragment obtained by 
running the same reaction in the absence of modified nucleotides. Lamprey 
genomic DNA was extracted from ca 100 mg liver tissue by proteinase K
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digestion (60 mM Tris, 100 mM EDTA, 0.5% SDS, pH=8.0, 400 pg/mL proteinase 
K) followed by two rounds of phenol:chloroform and chloroform extractions, 
precipitated with 3 M sodium acetate and 95% ethanol precipitation and 
resuspended in TE buffer (pH=7.4). Genomic DNA (40 pg) was then separately 
digested with 200 IU EcoR I and Hind III (Promega) respectively in appropriate
buffers at 37 °C overnight and run on a 0.8% agarose gel. The DNA was then 
transferred to a Nylon membrane using a non-alkaline procedure and probed 
with the DIG labeled DNA probe following the instructions for the Roche DIG- 
labeling and detection kit (Roche). The hybridized probes were detected using an 
Anti-DIG alkaline phosphatase coupled antibody (Roche) and CSPD 
chemiluminescent substrate (Roche).
General sequence manipulation and analysis. Hydropathy score was 
calculated and plotted by the 'octanoP program from the EMBOSS package. The 
position of the signal peptide was predicted using the SignalP server 
(http://www.cbs.dtu.dk/services/SignalP/). The functionally significant patterns 
and motifs and the protein domains of IGpH-ll were detected using the InterPro 
server (http://www.ebi.ac.uk/interpro/). The intron/exon organization of the 
lamprey GpH-R II was determined by running a blastn query against the sea 
lamprey trace database with the full or partial coding sequence of the receptor. 
The validity of the results were confirmed by analysis of their alignments with the 
known exon/exon junctions in the multiple alignment of vertebrate GpH-Rs. The 
similarity (percent identity) scores between IGpH-R I, IGpH-R II and the rest of 
the vertebrate glycoprotein hormone receptors were calculated using a Python 
script.
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Sequence alignment and molecular phvloaenv. The list of the sequences used 
in alignment are in Table 3. Glycoprotein hormone receptor protein sequences 
were aligned with muscle v3.6 [126], clustalw v1.83 [102] , t-coffee v5.03 [127] 
and probcons v1.1 [128] multiple sequence alignment programs. The
comparative quality scores of the alignments were estimated with the MUMSA 
program (v1.0) [129] and used for selection of the final alignment. The highest 
relative accuracies of the alignments were found for probcons and t-coffee which 
also are recorded with the highest scores in a series of benchmark tests using 
standardized input sequence datasets [129]. After visual inspection of the 
alignments the probcons output was further used for molecular sequence 
analysis due primarily to a more accurate alignment of the N-terminal signal 
peptide of the vertebrate GpH-Rs. Regions of the multiple alignment 
corresponding to the different functional domains of glycoprotein hormone 
receptors were identified and extracted based on the annotations of original 
GenBank sequence records and refined by comparison with the results of signal 
peptide, protein motifs and hydrophobicity analyses of IGpH-R I and II. Molecular 
phylogenies were reconstructed independently for the full amino-acid sequences 
cof vertebrate GpH-Rs as well as for the alignments of their functional domains. 
First, 1000 bootstrap replica of the initial full length gapped aligned sequence set 
were generated (seqboot, PHYLIP package [106] then maximum likelihood 
distances calculated (PHYLIP/protdist). The neighbor-joining trees 
(PHYLIP/neighbor) were consolidated into one consensus tree 
(PHYLIP/consense) and used as the guide tree for maximum likelihood 
estimation of branch lengths (PHYLIP/pproml). The same procedure was applied
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Figure 11. Molecular cloning of lamprey GpH-R II.
S1: DNA clone resulted from degenerate PCR amplification (Chapter I); S2: DNA fragment 
similar with vertebrate GpH-R exon 6 identified in P. marinus WGS trace files; S3 5' step-out 
RACE product; S4: PCR product obtained with gene specific primers; S5 3' end of IGpH-R II 
identified in P.marinus WGS trace files; S6: IGpH-R II cds.
to each functional domain alignment (extracellular segment including the signal 
peptide, the transmembrane domain and intracellular segment), with the 
difference that only 100 bootstrap replica were used for estimation of the 
molecular phylogenetic guide tree topology.
Many authors recommend removal of the gap-containing columns and of the 
highly divergent positions from the sequence alignments prior to molecular 
phylogeny reconstruction. It has been shown that this preliminary treatment of 
data may improve the accuracy of the phylogenetic signal, especially for DNA 
alignments of distant sequences (see for example [130]). However, the gap- 
removal is not recommended in the documentation of the PHYLIP pprotdist 
protein distance application [106] so the complete alignments generated by 
probcons were used directly, without any extra treatment.
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Figure 12. Lamprey GpH-R II nucleotide and protein sequences.
Signal peptide is underlined in black. The Signaling Specificity Domain (SSD or ’hinge') is 
underlined in gray while the transmembrane domain is surrounded by a black rectangle.
56
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Results
Lamprey GpH-R II full length coding sequence. An 879 bp DNA fragment was 
cloned and sequenced using degenerate primers based on the PRINTS 
glycoprotein hormone receptor (GLYCHORMONER) fingerprint. This fragment 
was shown to be highly similar with vertebrate FSH-R, LH-R and TSH-R 
receptors and distinct from the previously described lamprey glycoprotein 
hormone receptor (IGpH-R I) suggesting that it belongs to a novel, distinct 
receptor from the same subfamily. The step-out PCR based RACE experimental 
methodology previously used successfully to amplify the 5'end of IGpH-R I 
produced truncated fragments. Screening of lamprey genome sequencing base 
call database with the fragments of the lamprey GpH-R I resulted in identification 
of a sequencing clone containing a short fragment of 78 bp corresponding to the 
6th exon of the IGpH-R I but with a significantly different sequence.
The genomic fragment was then used for design of reverse primers 
amplification of the 5' end of cDNA as well as forward primers for amplification of 
the segment between the exon 6 and the transmembrane domain of the novel 
putative GpH-R. Step-out RACE [100] amplified a 583 bp DNA fragment while 
the amplification of the exon 6/TMD region resulted in cloning and sequencing of 
a 1012 bp DNA fragment. Moreover, screening the lamprey genomic clone 
sequences by Blast searches with IGpH-R I intracellular domain resulted in 
identification of multiple clones containing the remaining 3'-end fragment of the 
IGpH-R II. DNA sequences were then assembled by hand gene specific primers 
were designed against the putative translation initiation and stop sites which 
were used for amplification of the full DNA fragment corresponding to the IGpH-R
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II cds. The Kpn I (5' end) and Xho I (3* end) restriction enzyme recognition sites 
inserted in the primer sequences allowed cloning of the putative receptor in the 
pcDNA3.1/V5-His TOPO (Invitrogen) transfection vector cloning site and 
sequencing.
Figure 11. shows a schematic representation of the final full length IGpH-R II 
transcript and the methods used for obtaining the different fragments it was 
assembled from. The final IGpH-R II coding sequence is 2346 bp long encoding 
a 781 aa protein sequence.
Lamprey GpH-R II sequence domains and motifs. The SignalP server 
(http://www.cbs.dtu.dk/services/SianalP/. [103]) predicted a most probable signal 
peptide cutting site located 23 residues downstream from the translation start 
site.
Transmembrane domain was predicted between residues 414 (including 
signal peptide) and 681 (Figure 16). Seven putative glycosylation sites (at 
residues 78, 114, 199, 275, 302, 330, 724), and 4 protein kinase C (PKC) 
phosphorylation sites (at 258, 610, 687 and 730) were identified based on their 
specific Prosite signatures [104]. The PRINTS protein fingerprints, GPCR (G- 
Protein Coupled Receptors), GLYCHORMONER (glycoprotein hormone 
receptors) and TSHRECEPTOR (thyrotropin hormone receptor) were also 
detected (Figure 13).
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Figure 13. Protein fingerprints and motifs in the sequence of the lamprey GpH-R II.
Output screen from a search session on InterPro database ([131]) using the IGpH-R II as query 
sequence.
Genomic Southern result and intron/exon composition organization. Depending 
on the restriction enzyme used for digestion of the genomic DNA, only one or two 
bands were detected by Southern blot using a DIG-labeled probe of ca. 500 bp 
corresponding to a fragment of the transmembrane domain of IGpH-R I. Analysis 
of the exon number and location in IGpH-R II revealed the typical general 
organization of the tetrapod glycoprotein hormone receptor genes: all introns 
were found in the putative extracellular domain, the transmembrane and 
intracellular domains being encoded by the last exon.
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24i25 =25125=26=23 =26 =62 1488 aa
Figure 14. Exon/intron organization of the lamprey GpH-R I and II genes.
Position and size of exons are represented in comparison with mammalian (rat) LH, FSH and 
TSH receptors. The vertical dotted lines mark positions of the introns. The shaded areas indicate 
the position of the transmembrane domains in the coding sequences of all receptors. The widths 
of the squares are representative for the relative lengths of each receptor segment but are not 
drawn rigorously to scale.
Only 9 introns were found, same as in tetrapod FSH-R and TSH-R genes. The 
same analysis was done for the IGpH-R I with similar results. The exon/exon 
junctions in IGpH-R I were compared with the homologous positions in rat LH-R 
and found to correspond down to the last base, with the exception of the 
exon9/exon10 junction which in lamprey was found displaced a couple of bases 
towards the 5' end of the sequence.
Molecular phytogeny. Figure 17 shows the molecular phylogenetic 
relationships derived for the lamprey GpH-Rs with a selection of vertebrate 
homologs. The fruit fly (Drosophila melanogaster) GpH-R clearly positions as an 
outgroup.
The molecular phylogenetic relationships derived from the analysis of the full 
coding sequence of receptors describes the typical grouping of the GpH-Rs in 
three main clades: LH-R , FSH-R and TSH-R. The luteinizing hormone receptor 
clade is positioned as an outgroup to the monophyletic unit containing the FSH-R
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and TSH-R receptors. Both lamprey receptors form a distinct sister group of the 
TSH-R clade.
Table 3. Vertebrate GpH-Rs: database records, domain boundaries and IGpH-RI and II 
similarities.
Total CDS lengths include also the 1st Cys rich box and the signal peptide. The identity scores 
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FSHR_Bos_taurus L22319 695 42.7 44 .6 ssi 42 .0 4 3 .4 86 19.8 22.1 268 64 .9 65 .3 70 22.5 31.7
FS H R _B othropsJararaca A Y 1896 96 673 42.8 44 .9 lit; 40 .3 41 .6 66 2 6 .4 16.2 26 8 65.7 6 9 .4 68 21.7 38.6
FSHR_Cavia_porcellus A Y 0825 14 695 41.6 44 .7 22 4 42 .5 44 .7 86 18.7 22 .8 268 63.1 64 .9 70 21.7 32.7
FSHR_Clarias_gariepinus A J 012647 662 40.0 39.3 22 6 35 .7 37.7 57 31 .7 15.7 2 6 8 ; 63 .8 64 .9 62 15.8 22.8
FSHR_Cynops_pyrrhogaste
r
A B 0055 87 696 40.9 44.4 22 4 40 .7 41 .6 90 18 .9 18.6 268 64 .9 68 .3 68 20.8 33.7
FS H R _D anio_rerio A Y 278107 668 40.3 40.1 •225/; 35 .7 37 .7 59 29 .2 15.4 2 6 8 65.7 66 .8 62  ; 16.7 25.7
FSHR_Equus_asinus U 73659 687 41.5 43.8 224 41 .2 43 .8 78, . 20 .2 22.1 62 .3 63 .8 22.5 31.7
FS HR_Felis_catus AY521181 695 42.8 44.3 Ills 42 .0 43 .4 86 18.7 22.1 2 6 8 65 .7 66 .0 22.5 29.7
FSHR_G allus_gallus D87871 693 41.7 44.6 22 4 41 .2 41 .6 86 19.8 19.1 268 64.9 68 .3 68 20.8 36.6
FSH R _H om o_sapiens A Y 4291 04 695 41.2 45.0 2 2 4 39 .8 44 .2 86. 18.7 2 3 .5 268 63 .8 65 .3 70 21.7 32.7
FSHR_lctalurus_punctatus A F 28518 2 662 40.0 39.3 22 6 35 .7 37.7 57 , 31 .7 15.7 268 63.8 64 .6 62 15.0 22.8
FS H R _M acaca_fascicularis X 7 4 4 5 4 695 41 .4 45.1 2 2 4 39 .8 43 .8 86 18 .7 22 .8 268 64.2 65.7 70 21.7 34.7
FSHR_M acropus_eugenii A Y 082002 694 41.3 44 .5 224 41 .6 4 1 .6 87 18.5 2 0 .4 268 64.2 66.8 68 20.8 37.6
FSHR_M esocricetus_auratu
s
A Y 509907 694 40.9 43 .3 224 42 .0 43 .4 85 18.9 19.9 268 62 .3 64 .6 70 18.3 29.7
FSHR_M us_m usculus A F 09564 2 692 41 .4 42.3 224 41 .6 42 .0 85 2 0 .0 19.1 2 68 64 .2 63 .8 68 16.9 27.7
FSHR_Oncorhynchus_m yki
ss
A F 4 3 9 4 0 5 39.1 38.2 22 6 36 .6 4 0 .4 57 2 7 .0 14.2 269 63 .6 61 .7 54 12.3 17.8
FSHR_O vis_aries N M  0010092  
89
695 42.7 44.3 22 4 42 .9 43 .4 86 2 0 .9 22.1 268 64 .6 65 .3 70 20.8 30.7
FSHR_Podarcis_sicu la A J 292553 673 38.8 38.0 22 4 3 9 .4 32.7 67 2 5 .0 16.8 2 67 59.3 60.8 67 15.8 28.7
FSHR_Rattus_norvegicus N M _ 1 992 37 692 41.9 43.2 224 4 1 .6 4 1 .6 85 2 0 .0 20 .6 2 68 64.2 64 .9 68 20.3 30.7
F S H R _S alm o_salar D Q 837 298 660 39.3 38.5 226 37 .0 40 .8 57 2 7 .0 14.2 268, 64.2 62.7 54 13.2 17.8
FSHR_Sus_scrofa A F 0 2 5 3 7 7 695 42.3 43.7 22 4 41 .6 43 .8 86 18.7 20 .6 268 64 .9 65 .3 70 22.5 28.7
G THRII_O ncorhynchus_rho
durus
A B 0300 05 7 2 4 38.7 36.5 22 8 38 .9 36.1 97 17.3 13.1 268 61 .2 63 .8 76 18.8 14.5
LHR_Bos_taurus U 2 0504 701 40 .4 41.2 2 2 5 41 .6 4 1 .4 79 23 .8 19.7 268 61 .9 67 .2 77 16.7 20.7
LHR_C allithrixJacchus U 8 0673 676 41.3 41.5 225 40 .7 42 .3 52 27 .3 14.8 2 6 8 62.3 68 .3 77 18.3 23.4
LHR_Clarias_gariepinus A F 32454 0 710 40.2 37.1 2 25 42 .0 37 .9 86 19.8 15.3 268 63.1 63 .4 .83 16.5 15.3
LH R_D anio_rerio A Y 7141 33 708 39.7 37.4 2 2 5 39 .8 36.1 93 17 .2 13.8 2 6 8 64 .6 65.3 76 16.8 16.2
LHR_G allus_gallus N M _ 2 0 4 9 3 6 728 39.8 40.0 •225, 40.3 42 .7 109 15 .8 16.0 2 6 8 6 6 .4 68 .3 81 16.9 19.1
LHR_Hom o_sapiens S 5 7793 699 40.2 42.7 225 3 9 .4 44.1 79 22 .6 19.7 26 8 62.3 67 .9 77 18.3 21.6
LHR_lctalurus_punctatus A F 285181 696 40.1 36.9 225 3 9 .4 3 7 .9 78 2 4 .4 16 .4 2 6 8 60.8 61 .9 71 17.0 16.2
LHR_M us_m usculus N M _01 3582 700 40.9 41.1 liil 41 .2 41 .9 79 2 3 .8 19.7 268 62.7 67.5 74 18.3 21.3
LH R_O ncorhynchus_mykiss A F 4 3 9 4 0 4 727 38.7 36.5 i l l s : 39.3 36.1 100 17.0 13.1 268 61.2 63.8 76 18.8 14.5
LHR_Rattus_norvegicus N M _01 2978 700 40.9 41.3 m. 40 .7 42 .3 79 2 5 .0 2 0 .4 268 62.7 67 .9 74 19.2 19.4
LH R _S alm o_salar D Q 837 299 728 38.9 36.5 2 2 8 39 .3 36.1 100 17.0 13.1 268 61.2 63.8 76 20.5 14.5
LHR_Sus_scrofa N M _ 2 14449 696 41.2 42.1 225 4 1 .6 4 3 .2 79 2 5 .0 19.7 268 62.7 67 .9 74 16.9 20.0
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A B 030955 793 41.5 40.6 22 6 44.7 41 .0 141 . 15 .6 21.1 268 65 .7 69 .0 97 26.5 19.1
TS H R _B os_taurus N M _ 1 7 42 06 763 42.0 45.8 226 46.0 43 .6 129 14 .7 2 7 .5 268 6 6 .4 72 .8 87 21.6 23.7
TS H R _C anis_fam iliaris NM  0 0 1 0032  
85
764 42.9 45.9 22 6 46 .9 44 .9 130 1 5 .4 2 7 .3 268 66.8 7 2 .4 87 24.0 23.7
TS H  R_Clarias_gariepinus A Y 12 95 56 777 38 .8 39.5 22 6 43 .8 38.3 130 16 .2 2 2 .5 268 62.3 65 .3 101 17.7 18.9
TS H R _Felis_catus A F 21826 4 763 42.5 46.1 226 46 .5 45 .8 129 15 .5 2 5 .3 268 66 .4 72 .4 87 23.2 24.6
TS H R _G allus_gallus A B 2 3 4 6 1 3 761 42.2 46.4 226 46 .5 43 .6 131 18 .3 2 7 .8 268 64 .6 75 .0 85 22.8 22.7
TS H R _H om o_sapiens AY429111 764 42.6 45.9 22 6 46 .0 44 .9 130 16.2 2 5 .3 268 66.8 73.5 87 22 .4 22.9
TSHR_lctalurus_punctatus A Y 533543 778 38.5 39.5 22 6 41 .6 38.8 131 17 .6 2 3 .2 61 .9 66.0 101 18.4 17.4
TS H R _M orone_saxatilis A F239761 779 42.6 42.2 226 44.2 44.1 138 15.2 2 0 .9 2 6 8 66 .4 69.8 93 30.1 20.5
TSH R _M us_m usculus N M _011648 764 42 .4 46 .4 2 2 6 46.5 44.5 130 16.2 2 8 .0 268 66 .8 73.1 87 20.8 22.9
TS HR_O reochrom is_niloticu
s
A B 047390 778 42.3 42.3 226 43.8 42.3 138 15 .9 2 1 .5 268 66 .8 70 .5 93 27 .4 21.2
TS H R _O vis_aries NM  0 0 1 0094  
10
764 41.8 45.5 22 6 46.0 44.5 130 15 .4 2 5 .3 26 8 65 .7 72 .0 87 21.6 23.7
TS H R _R attus_norvegicus N M _01 2888 764 41.9 44.8 22 6 46.9 43.6 130 16.2 2 6 .7 268 65.3 70 .9 87 20.0 21.2
TS H R _Sus_scrofa A F 33824 9 764 42.3 46.2 226 45.1 45 .4 130 15 .4 2 6 .7 268 66 .8 73.1 87 23.2 24.6
G p H R I_ P e tro m yzo n _ m a rin u
s
A Y 7 5 0 6 8 8 719 100
T  , ...
3 9 .9
rjSpfeii
2 2 6 100 4 2 .3 5 2 100 12 7 2 6 8 100 6 7  9 111 100 19.9
G p H R II_ P e tro m yzo n _ m a rin
us
A Y 7 5 0 6 8 9 781 3 9 .9 100 2 2 6 42 .3 100 132 1 2 .7 100 2 6 8 6 7 .9 100 101 19.9 100
G pHR_Drosophila_m elanog
aster
U 47005 25.5 26.5 223 24.2 26.3 129 9.2 11.4 2 7 2 52 .2 50.0 76 12.5 15.6
A B
Figure 15. Lamprey genomic DNA Southern blot hybridization (A) and IGpH-R II tissue 
expression levels estimation by RT-PCR (B).
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A less refined phylogenetic 
analysis was included (in the gray 
box) to show the relationships 
between the glycoprotein
hormone receptors (and the new 
lamprey members of the 
subfamily) with a few of the 
mammalian LGR receptors. 
Reconstruction of molecular 
phylogenetic relathionships 
based on the protein domains 
resulted however, in apparent 
contradictory results, different 
domains showing distinct
molecular phylogenetic
relationships due probably to the 
differences in the relative 
functional/evolutionary 
constraints acting at the level of 
different domains.
Figure 16. Hydropathy profiles of lamprey GpH-R 
I, II compared with mammalian (mouse) LH-R 
hydropathy.
The profiles were generated by the 'octanol' 
application from EMBOSS package 
(http://emboss.sourceforge.net/)
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Figure 17. M olecular phylogenetic analysis o f glycoprotein horm one receptor protein 
sequences.
CDS=full aminoacid sequence, ED=extracellular domain, TMD=transmembrane domain, 
ID=intracellular domain. Molecular phylogenetic relationship with selected LGR is also 
represented in the shaded box.
Lamprey GpH-R II tissue expression pattern.The highest response in RT-PCR 
experiment was found for the thyroid sample tissue, followed by brain and 
gonads. Lower levels of the IGpH-R II transcript were also detected in intestine, 
skeletal muscle and intestine and no response was detected for the kidney tissue
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sample (Figure 15 B).
Discussion
A novel glycoprotein hormone receptor (IGpH-R II) was identified and cloned 
from the sea lamprey thyroid tissue. The protein sequence as deduced by virtual 
translation of the open reading frame is 781 residues in length and highly similar 
with Gnathostome GpH-Rs (FSH-R, LH-R, TSH-R).
Its transcripts were detected in thyroid tissue but also in other tissues (gonad, 
liver, skeletal muscle, gut and brain). The translated region of IGpH-R II gene 
consists of 10 exons alternating with 9 introns. The introns are located 
exclusively in the predicted extracellular domain of the mature protein and the 
lengths of the exons 2 to 9 are identical with lengths of corresponding exons in 
tetrapod GpH-Rs. The molecular phylogeny of the representative members of the 
glycoprotein hormone receptor family in vertebrates suggests a close 
evolutionary relationship between this receptor and the thyrotropin hormone 
receptor subfamily.
This is the second glycoprotein hormone receptor identified in this Agnathan 
species. The global identity between the two lamprey GpH-R (40%) was found to 
be lower than the identity score calculated between each of these two receptors 
and the tetrapod members of this protein family (LH-R, FSH-R and TSH-R). The 
lowest identity score was found in respect to the teleost GpH-Rs.
The most obvious feature of the coding sequence of IGpH-R II is the presence 
of a long linker fragment (SSD or 'hinge') located in between the Leu Rich 
Domain (LRD) of the extracellular segment (ED) and the transmembrane domain
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(TMD). This is one of the longest linker fragment described in all vertebrate 
glycoprotein hormone receptors. This comes in opposition with the similar region 
of the IGpH-R I which is the shortest SSD/hinge segment amongst all vertebrate 
GpH-Rs [124]. The long LRD-TMD linker segment, due to the presence of an 
approximately 50 residue insert is a characteristic of the thyrotropin receptors in 
vertebrates [27]. This intervening region has been characterized in relation to an 
important feature associated with TSH-R that is its cleavage during receptor 
maturation and its existence on the cell surface as a functional receptor 
composed of two subunits linked by disulfide bridges [132], The receptor 
cleavage and reassociation is accompanied by the removal of the 50 residue 
insert in the ED/TMD linker region [133]. However, the fine details of the 
mechanisms of this process are not yet fully understood, due primarily to the low 
similarity between GpH-R paralogs in this region [134]. In fact, the lowest identity 
score for lamprey GpH-R II was calculated for the alignments of this region 
(Table 3). However, although its length as well as the identity scores bring the 
IGpH-R II closer to the tetrapod thyrotropin receptor group, the linker region of 
this receptor lacks motifs found to be important for the function of TSH-R in these 
animals. For example, the terminal end of the (present) 3rd Cys-rich box upstream 
of the first transmembrane segment lacks the Y-[DE]-Y motif related by various 
authors to a functionally important Y-sulfation in mammalian TSH-Rs [111]. 
Lamprey GpH-R I also lacks this motif and in this respect both lamprey 
glycoprotein hormone receptors resemble the teleost TSH-Rs which suggests 
that functional importance of Y-sulfation is a characteristic acquired later in the 
evolution of GpH-Rs, after divergence of Tetrapod lineages.
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The presence of 10 exons in the gene structure of the lamprey GpH-R genes 
suggests a closer evolutionary relationship of IGpH-R II with thyrotropin and 
follitropin receptors in Gnathostomes. Lamprey receptors lack the intra­
transmembrane domain introns found in many teleost fish [21] as well as the 
extracellular domain 10th intron characteristic to Gnathostome luteinizing 
hormone receptor.
The molecular phylogenetic analysis revealed contradictory phylogenetic 
signals for functional domains of GpH-Rs. The molecular phylogenetic results are 
the result of combined functional and evolutionary constraints acting on 
nucleotide/amino acid sequence change during evolution. The interacting protein 
domains in protein interacting partners (e.g. GpH/GpH-R ED) are considered 
exposed to similar functional constraints and consequently will evolve with similar 
rates (see for example [135]), phenomenon usually termed co-evolution of 
interacting partners [56]. From this perspective, the extracellular domain reflects 
to some extent the evolution of the corresponding glycoprotein hormone. It is 
interesting however to notice that the unique lamprey glycoprotein hormone beta 
chain identified to date was shown to act as an outgroup to the vertebrate GpH 
beta chain clade. One explanation can be related to the finding that correlated 
evolutionary change might be due to factors external to the immediate amino 
acid composition of interacting partners (receptor/ligand) at the contact points. 
Other mechanisms might be the constraints imposed by the intra molecular 
interactions between different residues [136], intermolecuiar, functionally 
important interactions between the receptors on the cell membrane [137] or the 
similarity in expression requirements of the proteins [64].
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Tissue expression pattern of IGpH-R II transcripts shows a wide spread 
distribution in several tissues. It is nowadays becoming more and more obvious 
the importance of the transcriptional control in the functional evolutionary 
divergence of members of a protein interacting network [64]. The tissue 
expression pattern of IGpH-R II is in accordance with previous findings about the 
specificity of transcriptional control/tissue expression in different taxa indicating a 
lower specificity in less evolved organisms ([135], [21], [38]). The high similarity 
with thyrotropin receptor is also in agreement with this result, considering that the 
thyrotropin receptor has less stringent control of its expression when compared 
to gonadotropin receptor counterparts [134].
The genomic DNA Southern hybridization results suggest that IGpH-R I and 
IGpH-R II are likely the only representative glycoprotein hormone receptors in 
this species. Extensive Blast searches performed within the preliminary lamprey 
whole genome sequencing data failed to identify genomic clones belonging to a 
different GpH-R (data not shown). We then hypothesize that IGpH-R I and IGpH- 
R II are the only members of the glycoprotein hormone receptor subfamily in 
lamprey. They are descendants of the thyrotropin receptor-like molecular 
ancestors of the GpH-Rs in Gnathostomes and are likely the result of the 
genome duplication event hypothesized to have taken place before the 
divergence of lamprey lineage ([138], [139], [72]).
68
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER III
FUNCTIONAL DIVERGENCE OF GLYCOPROTEIN HORMONE RECEPTORS.
Introduction
The thyroid and gonadal steroid hormone secretions as well as development 
of the thyroid and gonads in vertebrates are controlled by three closely related 
glycoprotein hormone (GpH)/glycoprotein hormone receptor (GpH-R) tandems. 
Thyrotropin hormone (TSH) is released from anterior pituitary thyrotrophs and 
binds to the thyrotropin hormone receptor (TSH-R) in the thyroid modulating the 
gene expression in this tissue [11]. Similarly, the pituitary follicle stimulating 
hormone (FSH) binds to the cognate receptor (FSH-R) expressed on the 
membrane of the testicular Sertoli or ovarian granulosa cells (FSH-R) [15]. The 
expression of the receptor for the pituitary luteinizing hormone (LH-R) was 
detected predominantly in the Leydig cells of the testes and in theca, interstitial, 
granulosa and luteal cells of the ovary [14], Glycoprotein hormones have a 
similar molecular organization being dimeric proteins with one subunit (alpha) 
present in all GpHs while the beta subunit is specific to each hormone. 
Correspondingly, their receptors are highly similar having a large extracellular 
domain (ED) containing a Leu Rich Domain (LRD) linked to a rhodopsin-like 
transmembrane domain (TMD) through a highly divergent linker region (Signal 
Specificity Domain, SSD or 'hinge' region). The third major segment is the 
intracellular domain, which also shows a lower similarity score.
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The physiology of the hypothalamic-pituitary-thyroid and hypothalamic- 
pituitary-gonadal axes has been extensively studied in vertebrates, particularly in 
mammals. The hormonal factors of these axes in general and GpH/GpH-R 
couples in particular have also been subject to numerous investigations, due to 
their involvement in certain pathological conditions in humans [140]. Especially in 
the last couple of years, a number of hormones and receptors from this group 
have been identified and described in early evolved vertebrate lineages e.g. in 
fish (see Chapter I).
However, little is known about the evolutionary origin of this intricate endocrine 
control system. It is widely accepted that all glycoprotein hormone as well as their 
receptors are descendants of common molecular ancestors and that their 
duplication and divergent subfunctionalization started before the divergence of 
the vertebrates. The search for the patterns of endocrine control similar with 
HPT/G axes in the closest relatives of vertebrates, the Protochordates has 
provided important clues but no definite answer to the question of how a high 
physiological specificity has emerged from interaction of molecular species which 
show otherwise close functional and structural characteristics. Nine forms of 
gonadotropin releasing hormone (GnRH) were identified in Urochordates ([141], 
[142]). It was also reported that mammalian GnRH is able to induce steroid 
synthesis in isolated C.intestinalis gonads [141] and synthetic forms of 
urochordate GnRH induced gamete release when injected in adult C.intestinalis 
[142]. Although Protochordates lack thyroid follicles, the presence of thyroid like 
hormones has been described in blood, endostyle and tunic of the adult 
urochordates as well as in their larvae [115]. To date, no evidence has been
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found for the presence of gonadotropin or thyrotropin like hormones in 
urochordates. The closest relative of the glycoprotein hormone receptors 
annotated or detectable by Blast searches with GpH-R sequence queries in the 
Ciona intestinalis genome (http://genome.jgi-psf.org/Cioin2/Cioin2.hhome.html) 
was a homolog of the relaxin receptor LGR7 (data not shown). In 
Cephalochordates (amphioxus) GnRH was found [116], LH ([143], [144]) and 
TRH immunoreactivity as well as steroid and thyroid hormones (reviewed in 
[115]). However, no evidence for the presence of glycoprotein hormone receptors 
is available in these organisms. All these data suggest a possible direct 
relationship between neuroendocrine factors (GnRH, TRH) and secretion of 
thyroid-like or gonadal steroid-like hormones from peripheral glandular tissues 
and/or activation of gametogenesis or thyroid like functions in these primitive 
organisms [75]. The available evidence offers little support for either the 
existence of neural control of a pituitary-like master gland (a projection of the 
brain contacting the Hatschek's pit in amphioxus was described as a possible 
predecessor of the hypothalamic-pituitary system in vertebrates [121]) or for the 
existence of a pituitary/peripheral gland control level.
From this perspective, the appearance of the hypothalamic-pituitary- 
thyroid/gonadal axes in vertebrates coincides with the interpolation of a new level 
[120] in the respective neural-peripheral gland control hierarchy: the glycoprotein 
hormone/glycoprotein hormone receptor, concomitantly with the development of 
specialized glandular tissues (the pituitary).
In mammals, the GpH/GpH-R system exhibits two characteristics tightly 
related to their proper function under normal physiological condition: the
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specificity of their temporal and tissue expression profiles and selectivity in their 
interaction with the ligands ([15], [27], [16], [135]). These characteristics have 
evolved during divergent evolution of the ancestral duplicated genes which were 
inherently neither specific in their expression nor selective in their ligand 
affinities.
The sea lamprey is, together with the hagfish, the only actual representative of 
the jawless organisms (Agnatha). It was estimated based on DNA data ([145]) 
that the Cyclostomes (lamprey and hagfishes) have diverged from the ancestral 
Agnathans during the early Paleozoic era, 535-462 mya. Moreover, the fossil 
records suggest that the lamprey lineage diverged directly from the ancestral 
Agnathans ([73], [71]). This makes this species an excellent object of study for 
understanding the endocrinology of the ancestors of present day vertebrates 
[72].
Two novel glycoprotein hormone receptors were identified and described in 
this species ([124], Chapter III) as well as the putative beta chain of a novel 
glycoprotein hormone [76]. This is the only GpH detected so far in lamprey using 
molecular biology methods or by screening the lamprey whole genome 
sequencing draft data. Molecular phylogenetic relationships between vertebrate 
GpH beta chains shows the lamprey sequence removed from the beta TSH, FSH 
and LH clade, acting as an outgroup for all vertebrate glycoprotein hormones 
beta subunits [76]). The receptor sequences on the other hand are clustered as a 
sister group of the thyrotropin receptors when the molecular phylogenetic 
relationships are derived using the whole coding sequence data. A different 
picture was observed when individual functional domains were used in
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phylogenetic analysis. The extracellular domain tree exhibits the same topology 
as the full coding sequence. The transmembrane domain suggests a phylogeny 
where the IGpH-R I acts as an outgroup to vertebrate GpH-Rs while the IGpH-R 
II keeps its monophyletic position with the TSH-R sequences ( see Chapter III).
We hypothesize that lamprey GpH-R I and II are homologs of later evolved 
vertebrates LH, FSH and TSH receptors, descending from a common ancestor 
which was TSH-R-like. The difference in phylogenetic signals for different 
domains is due to the functional constraints acting differentially at the level of 
different segments of the receptor. The extracellular domain tree topology reflects 
a similar pattern of substitution due to the interaction with a single ligand while 
the transmembrane domain is more significant in respect to the actual 
evolutionary relationships between members of the GpH-R subfamily [130].
Methods and Materials
Glycoprotein hormone receptors. Rat luteinizing hormone receptor was a gift 
from Dr. Bill Moyle. Lamprey glycoprotein hormone receptor I was obtained 
through molecular cloning from lamprey testes tissue [124].
Hormones. Ovine LH and ovine TSH were obtained from National Hormone & 
Peptide Program (NHPP). Human FSH, human CG and the pregnant mare 
serum gonadotropin (PMS) were purchased from Sigma (Sigma-Aldrich Corp., 
St-Louis).
Preparation of the chimeric lamorev/rat glycoprotein hormone receptor 
chimeric constructs. Rat luteinizing hormone receptor was subcloned in 
pcDNA3.1/V5-His TOPO (Invitrogen, Carlsbad CA). The lamprey GpH-R I and rat
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Figure 18. Preparation of chimeric receptors by Splicing by Overlap Extension (SOE-PCR).
The figure shows an example of application of the procedure at the level of the rat LRD/lamprey 
SSD junction.
LH-R DNA fragments were combined in chimeric functional receptors using the 
general SOE-PCR (Splicing by Overlap Extension, Figure 18) methodology. The 
method or variants of this method have been described by different authors and 
applied to a wide range of molecules ([146], [147], [148], [149]).
The two upstream and downstream receptor fragments intended to be spliced
together were first amplified with gene 
specific primers and universal primers (T7 
and BGH respectively). The 3' reverse primer 
for the upstream fragment was usually 
chosen as a mutagenic primer, containing at 
its 5' end a region complementary to the 5' 
end of the downstream fragment. The
Figure 19. Agarose gel of the 
products of SOE-PCR amplification.
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amplifications were done using the Phusion(r) High Fidelity Polymerase from 
Finnzymes ((Finnzymes/NEB, Ipswich, MA).
Typical amplification conditions at this step included an initial denaturation at
98 °C for 3 min followed by cycling with denaturation step at 98 °C for 30 sec, 
annealing 68 °C 10 sec and extension 30 sec at 72 °C repeated 40 times; the 
final extension was carried out for 10 min at 72 °C. The amplification products 
were then purified by gel electrophoresis and their approximate amount 
estimated by densitometry. The PCR splicing step was conducted in two phases. 
In the first phase the receptor fragments were added to the Phusion(r) Master 
Mix in amounts adjusted to ensure an approximate 1:1 molar ratio between them
then run through 10 cycles amplification with denaturation step 30 sec at 98 °C, 
annealing 10 sec at 60 °C and extension 30 sec at 72 °C. In the second phase, 
primers designed against the 5' end of the upstream fragment and 3' end of the 
downstream fragment were added to the reaction to a final concentration of 0.2
pM. The same program with annealing temperature increased to 65 °C was then 
run for 35 cycles.
The 5' and 3' primers were designed to include a Kpn I restriction enzyme 
recognition site and an Age I recognition site site respectively to allow sub­
cloning of the full length hybrid receptor. The 5' primers also included the Kozak 
consensus for expression in eukaryotic cells. After amplification, the PCR 
product was checked on agarose gel. Usually the spliced product was easy to 
recognize based on its size compared with the expected total size of the
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construct. A typical agarose gel of the products of SOE-PCR amplification is 
reproduced in Figure 19.
After purification from the gel fragments, the chimeric receptors were digested 
with Kpn I/Age I restriction enzymes (5 IU/25 pL reaction, o/n) and ligated into the 
Kpn I/Age I linearized pcDNA3.1A/5-His TOPO eukaryotic expression vector and 
transfected into the TOP10 (Invitrogen, Carlsbad CA) cells. The plasmids were 
prepared for transfection by miniprep (Wizard DNA Preparation System, 
Promega Corp., Madison Wl), resuspended in endotoxin free TE buffer and 
verified by Kpn I/Age I restriction digest. The amount and quality of plasmid DNA 
was estimated by optical density measurements at 260 and 280 nm. 
Concentrations of plasmids in the stock solutions used for transfection were 
adjusted at the same value based on their OD concentrations and on agarose gel 
densitometric measurements of restriction digest products. The pCF3CF2 and 
pCF1CF4, containing all the lamprey/rat inter-domain junctions were verified by 
sequencing (SeqWright, Texas) in order to validate the experimental 
methodology for construction of chimeric receptors, using lamprey GpH-R I gene 
specific and universal (T7 and BGH) primers.
The COS-7 cell culture maintenance and transfection procedure. The general 
COS-7 culture maintenance was described previously (see Chapter II).
The cAMP dependent signal transduction assay. The experimental protocol for 
functional assay of cAMP dependent signal transduction activation by membrane 
receptors using the Secreted Alkaline Phosphatase (SEAP) reporter system is 
presented in detail in Appendix A. Briefly, the day before transfection the COS-7 
cultures grown in T75 flasks in C02 (5%) humidified incubator in DMEM with 10%
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FBS were cut with 2 mL Trypsin, resuspended in the same medium at 4 x 105 
cells/mL and plated on 6 or 3.5 cm Petri dishes or in 12 well plates depending on 
the design of the experiment. The next day three hours before transfection the 
medium was replaced with fresh DMEM 10% FBS then co-transfected with 
receptor construct/ reporter plasmid mixtures at a constant receptor:reporter 
mass ratio of 1:7 using the Lipofectamine 2000 transfection reagent following the 
manufacturers' (Invitrogen) instructions. The next day the cells were cut with 
Trypsin, resuspended at 5 x 105 cells/mL count, plated on 96 well plates at 100 
pL/well and returned in the C02 incubator over night. Different layouts for the 
placement of the constructs on the plate were used in order to minimize the 
systematic errors associated with the position on the plate. In the next step the 
culture medium was removed, cells washed with serum free DMEM, overlayed 
with 100 ijL serum free DMEM and incubated over night.
Different concentrations of hormones were prepared in a base buffer 
containing phenol red free DMEM, 1 mg/mL BSA and 0.2 mM IBMX for all 
samples. The serum free DMEM was gently aspirated using a multichannel 
pipette and immediately replaced with 100 pL of stimulation medium and 
returned in the C02 incubator for overnight. The assay for SEAP activity in the 
culture medium was started with centrifugation of the culture plates and transfer
of the medium to new 96 well plates which were incubated subsequently at 65 °C 
for 20 min to remove the native alkaline phosphatase activity. The culture 
medium was then mixed with 2X SEAP reaction buffer (2M diethanolamine/HCI 
DEA, 1 mM MgCI2, pH = 9.8) containing 18 mM paranitrophenylphosphate 
(pNPP) chromogenic alkaline phosphatase substrate and immediately transfered
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to the plate reader (BioTek Inc., Winooski, VT) set at 405 nm for measuring the 
initial point in the progress curve.
The optical density measurements were then taken at various time intervals, 
increasing from ca. 10 min in the first hour of incubation to 6 h over a period of 24 
h. The absorbance data table was immediately saved into a text file and the 
automatically inserted timestamps were used to construct the SEAP reaction 
progression curves.
Experimental data analysis. The alkaline phosphatase activity (initial rate) is a 
measure of the relative impact of different transfected recombinant proteins 
and/or treatments on the cAMP dependent signal transduction pathway.
The SEAP reaction progress curve and estimation of initial rate.
o 500 1000 1 5 0 0 2000 2 5 0 0 3 0 0 0 3 5 0 0
Figure 20. Calculation of the SEAP initial rate.
The curve through experimental points was obtained by calculation of the parameters of an 
empirical saturation function (eq 1) by non-linear regression on all the points of the 
progression curve. The parameters obtained were used to calculate and plot the linear 
function f(x)=slope * x (thick line). The line obtained by a linear regression procedure on the 
first 6 points of the graph is also represented for comparison (thin line).
Initial reactions rates were estimated from the OD vs time progress curves in
two steps. In the first step the parameters of an empirical function describing a
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saturation kinetics (eq 1, Amax, K empirical parameters, t is time) were estimated 
by non-linear regression (Figure 20).
The initial estimates of the parameters were obtained by linear regression on 
the first 4 points of the curve (usually corresponding to a reaction time of less 
than 2 hours). The initial rates (S) were calculated using the analytical expression 
for the 151 derivative of the saturation function using the parameters derived from 
regression (eq 2). The initial rate for each experimental sample is the sum of the 
contributions of three processes (eq 3): (i) the basal accumulation of cAMP due 
to the inhibition of the phosphodiesterase by IBMX (Sbasai), (ii) the accumulation 
of cAMP due to the constitutive activity of the receptor construct ( S C O n s t i t )  and (iii) 
the accumulation of cAMP due to the treatment the culture was exposed to 
(hormone ligand or forskolin) Streat. The value for SEAP activity determined in the 
culture media for concentration of ligand equal to zero (So) represents the sum 
between the basal value (S0) and the effect of the constitutive activity of the 
receptor constructs ( S COnsm ) (eq 5). The values of S0 were estimated 
experimentally as the enzyme activity in the medium samples obtained from 
culture transfected with the blank vector (pcDNA3.1 A/5-His TOPO) (eq 6).
f  (x) = Amax * ( 1 -  exp ( -  K * t  ) ) (1)
S = f  ' (0 ) = Amax * K (2 )
( 3 )
( f o r s k o l i n )  (4)
(dose=0) ( 5 )
(pcDNA3.1) ( 6 )
S b la n k  )  /  (  S t o t a l F s k  S q )c o n s t i t ( 7 )
% S  -  1 0 0  *  (  S t o t a l  ~  S o  )  /  (  S t o t a l F s k  -  S o  ) (8)
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Figure 21. Diagram of the chimeric rat LH-R/lamprey GpH-R I chimeric receptors.
Differences in means on the dose/response curves were tested using one way 
ANOVA (R/oneway. test) and pairwise comparison of means was done using 
Welch two sample t-test (R/t.test). All numerical values are reported as 
means+/-S.E.M. calculated from experimental outcomes of at least two different
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transfections with duplicate treatment samples (dose/response data) or at least 
five different transfections in duplicate (constitutive activity data).
Calculations and data plots were done in the R (http://www.r-proiect.org/. 
[150]) environment, graphics were subsequently edited in the inkscape SVG 
editor (http://www.inkscape.org/) in order to include supplementary information 
about the constructs and ligands used. The R scripts written for the data analysis 
are available from the author upon request.
Results
The lamprev IGdH-R I /  rat LH-R chimeric constructs. Figure 21 shows a 
diagramatic representation of the receptor constructs prepared and used in this 
study. They are grouped in 6 series, Series A contains domain swapped 
constructs downstream of a rat signal peptide; Series B contains the same 
constructs with signal peptide replaced by lamprey signal peptide. These first two 
chimeric receptor sets lack the FLAG tag and were used for cAMP signal 
transduction assays using two concentrations of ovine LH and ovine TSH as 
stimuli. The purpose of the experiments involving these constructs was to test for 
the possible effect of the signal peptide on the capability of cells transfected with 
these constructs to respond to hormone stimulation and to obtain a preliminary 
estimate of the effect of gonadotropins versus thyrotropin.
Series C and D were obtained from the constructs of the series A (rat signal 
peptide containing chimeras) by insertion of a FLAG tag 'DYKDDDDK' 
(GACTACAAGGACGATGACGATAAG) in between the rat signal peptide and the 
mature peptide using the SOE-PCR procedure described above. The presence
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of the FLAG tag allows usage of commercial anti-FLAG antibodies for detection 
of the protein either on the cell surface by a cell-based ELISA type of assay or 
intracellularly by Western blotting. However, the tag was not used in this study at 
this stage. Constructs of the series C and D differ by the presence of the lamprey 
(series C) or rat (series D) extracellular domain (including SSD) upstream of all 
combinations of the transmembrane and intracellular domains.
The constructs of C and D series were used as templates for synthesis of the 
chimeric receptors classified under the series E and F which were prepared in 
order to test for the effect of the reciprocal exchange of the full or partial signal 
specificity domains (SSD) of lamprey GpH-R I and rat LH-R on the ability of the 
construct to recognize and respond to luteinizing hormone treatment.
The Signaling Specificity Domain (SSD) or 'hinge' segment is present in all 
glycoprotein hormone receptors in between the Leu Rich Repeat Domain (LRD) 
and the N-terminal end of the transmembrane domain (TMD).
rat LH-R












Figure 22. Details of the rat LH-R/lamprey GpH-R I chimeras SSD level junctions.
Arrowed vertical lines mark the splicing sites between rat LH-R and lamprey GpH-R I.
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This is a region of poorly defined structural organization considered initially a 
mere flexible arm linking the LRD and TMD. However, new experimental 
evidence ([23], [17], [151]) suggests that it contains functionally important 
residues, critically involved in the selective interaction with the ligand and in 
signal transduction. The SSD contains the exon9/exon10 junction in all GpH-Rs, 
as well as the exon10/exon11 junction in luteinizing hormone receptors.
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Figure 23. Effect of oLH and oTSH on chimeric IGpH-R l/rLH-R receptors series A and B.
A detailed diagram of the rat and lamprey SSD is presented in Figure 
22.Fragments of the chimeric receptors from series C and D (domain swapped) 
were spliced at the level of the LRD/SSD boundary (more precisely 8 residues 
upstream the N-terminal end of the SSD), of the exon9/exon10 junctions (rat, 
lamprey) and exon10/exon11 (rat) junction. This resulted in 6 different 
combinations of the SSD fragments inserted in the original 8 domain swapped 
chimeras (Figure 21, E and F).
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Preliminary estimation of the GdH-R chimeras to oLH and oTSH. The effects
of ovine LH and ovine TSH were tested using the constructs of the series A and 
B (Figure 23).
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Figure 24. Analysis of constitutive activity of rat LH-R/lamprey GpH-R I chimeric receptors 
series C-F.
The chimeras of the series C and D (ED, TMD and ID domain swap experiment) are marked by 
open squares. The units are fold increase over the response to 5 uM forskolin treatment of the 
same culture, same transfection, expressed as means +/- S.E.M. The asterisks mark the values 
significantly different from blank (pCRE-SEAP+pcDNA3.1).
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The results were calculated as fold increase over the corresponding values 
obtained when concentration of stimulus was zero. This implies that the values 
obtained here do not account correctly for the relative contribution of the 
constitutive activity over the effect of the hormone exposure.
This can be noticed for example in the case of the pRF8LF9 construct (rat LH- 
R with lamprey intracellular domain) where the effect of the oLH is 
underestimated due to the high constitutive activity of this chimera (see next 
section).
However, the results in this experiment indicate a high response for the 
constructs containing the rat extracellular domain and suggest that the presence 
of the IGpH-R I signal peptide does not impair the activation of the signal 
transduction by oLH treatment. The response to the thyrotropin treatment on the 
other hand was low for all constructs so this ligand was not used in the next 
steps.
Analysis of the constitutive activity. The constructs of the series C to D (FLAG 
containing chimeras), D and F (SSD modified chimeras) were used for 
assessment of the constitutive activity in COS-7 cells. Figure 24 shows the 
SEAP activities in the culture media at concentration of ligand equal to zero, 
normalized in respect to the response to forskolin 5 pM treatment in the same 
experiment. Three constructs showed a significantly (P<0.05) higher constitutive 
activity compared with both constitutive activity of IGpH-R I (pRF2LF3 construct) 
and rLH-R (pRF1 construct): pCF40CF20 (rat LH-R with lamprey SSD and ID), 
pCF40LF13 (lamprey GpH-R I with rat ED) and pRF8LF9_FLAG (rat LH-R with 
lamprey ID).
85
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.










0.0 0.2 0.4 0.6 0.8 1.0
Dose (ug or IU /mL)
0.0 0.2 0.4 0.6 0.8




□  human CG 


















0.0 0.2 0.4 0.6 0.8 1.0
Dose (ug or IU /mL)
pCF3RF5_FLAG










0.0 0.2 0.4 0.6 0.8 1.0
Dose (ug or IU /mL)
Figure 25. Response of domain-swapped rat LH-R I lamprey GpH-R I chimeras (series C, 
lamprey ED) to oLH, hFSH, hCG and PMSG.
Figure 25 and Figure 26 show the dose/response curves obtained by 
treatment of each of the chimeric constructs from series C and D with four 
glycoprotein hormones (ovine luteinizing hormone oLH, human chorionic
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Figure 26. Response of domain-swapped rat LH-R I lamprey GpH-R I chimeras (series D, 
rat ED) to oLH, hFSH, hCG and PMSG..
Analysis of Series C (with lamprey extracellular domain) chimeras did not 
result in a significant response for any of the hormones tested with one 
exception: the response of the pCF3CF2_FLAG construct (lamprey GpH-R I with 
rat TMD) to luteinizing hormone oLH stimulation.
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Receptors of the series D (rat extracellular domain) resulted in a high signal 
detected in response to stimulation with any of oLH, hCG and PMSG hormones. 
The follicle stimulating hormone hFSH was inactive with the exception of one 
construct, pRF8LF9_FLAG (rat LH-R with lamprey intracellular domain ID) for 
which a signal almost as high as for hCG and PMSG was detected.
Effect of SSD modification on the response to ovine LH treatment. 23 
lamprey/rat chimeras were prepared by reciprocal exchanges of the fragments of 
the SSD segment of both receptors applied to each of the constructs in series C 
and D.
p€F36CF23 0 F H K M B 4  pCF36CF24 O F M O «
pCF37CF29 pCF37CF30 O F B W X Z D *
- O -  pCF3BCF32 O F I
0.1 0 J  «3.3 0,4 0.S 0.« 0.7 0.« 0.9





0 0.1 0.7 0.3 0.4 0 .5  0-ft 0 .7
Dose (ug/mL ovine LH)
0.0 0.9 1
Figure 27. Effect of SSD manipulation on the response of chimeras containing lamprey ED 
to oLH stimulation.
Diagrams of the chimeric receptors are represented above the dose-response plots.
These constructs were then used for screening the change in their response 
upon exposure of the transfected cells to mammalian (ovine) LH. Only the most 
significant results are reported here. Insertion of the rat SSD in the wild type 
IGpH-R I resulted in increased response to hormone treatment (Figure 27 left 
panel, pCF36CF23).
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This increase was lost when the N-terminal fragment of lamprey SSD (see 
Figure 22) replaced the corresponding region of the rat SSD (pCF37CF29). The 
responsiveness of the construct to oLH was restored after removal of the rat 
fragment corresponding to exon 10 (pCF38CF32), this chimera inducing an even 
higher stimulation of SEAP secretion than the rat SSD only receptor at higher 
concentrations of ligand.
A similar pattern was observed when the same manipulations of the SSD were 
applied to the lamprey ED/ratTMD hybrid (Figure 27, right panel): insertion of the 
rat SSD upstream the rat TMD (pCF36CF24) resulted in increased response of 
the chimera to oLH treatment. Replacement of N-terminal fragment with lamprey 
sequence (pCF37CF30) resulted in an unresponsive construct. Further 
elimination of the 10th exon sequence of rat (pCF38CF33) restored the activation 
of the construct at even higher levels.
Discussion
Construction of chimeric proteins is an experimental tool that is widely used in 
the study of functional properties of glycoprotein hormone receptors. This 
approach was particularly effective in identification and localization of the 
structural determinants of the ligand binding selectivity among thyrotropin, 
lutropin and follitropin members of this subfamily of receptors ([89], [135], [14],
[17]). Depending on the specifics of the experimental designs applied, smaller or 
larger fragments of one receptor are inserted into a second one and the 
properties of the new construct are evaluated by different experimental methods 
in respect to the properties of the original proteins as a reference.
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Application of this methodology to investigate the functional divergence 
between a lamprey GpH-R (IGpH-R I) and a mammalian (rat) GpH-R (rl_H-R) 
resulted in identification of specific combination of domains exhibiting functional 
properties which are distinct from their parent receptors (lamprey and rat) in 
respect to both ligand selectivity and constitutive activity. This suggests that 
evolutionary change at the level of individual domains did not altered 
fundamentally their original functions, but receptor selectivities have been refined 
by subtle correlated changes in multiple domains under the specific constraint of 
binding of increasingly divergent ligands.
Although not always explicitely stated, this experimental approach is based on 
an assumption of a non-random effect of the transfer of a particular protein 
fragment from one molecule to another, i.e. on an assumption of functional 
homology between the protein segments under investigation. This relies 
ultimately on the concept of the proteins as strings of domains, each domain 
being a functional unit, exposed to specific evolutionary constraints.
In the case of the GpH-R subfamily of receptors, the main structural/functional 
units usually characterized are the extracellular domain (ED), the transmembrane 
domain (TMD) and the intracellular domain (ID). Their functions are, respectively, 
the binding of the ligand, the transfer of signal to the intracellular medium and the 
regulation of receptor silencing and internalization.
Experimental evidence collected especially in the last decade suggested a 
finer functional specialization within these broader structural units, leading to 
identification of the roles of conserved residues within the Leu Rich Repeat 
Domain (LRD) [152] and the Cys Rich boxes 1,2 and 3 [153].
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Moreover, the formerly neglected poorly conserved, low complexity or 
intrinsically disordered protein regions have received new attention after the 
collection of experimental evidence indicating that these regions may have an 
important role in the protein function both in general [154] or in the particular 
case of the LRD/TMD linker of GpH-Rs ([155], [23]).
Lamprey GpH-R is the most distant member of the vertebrate group of 
glycoprotein hormone receptors identified to date. A glycoprotein hormone beta 
chain was also described in lamprey and its properties are being investigated but 
no data is available at this point on the binding to IGpH-R I or signal transduction 
activation [76]. The IGpH-R I domains were assigned based on a multiple 
alignment with the vertebrate FSH-Rs, LH-Rs and TSH-Rs but the only support 
for their putative roles is the similarity scores with homologous regions of 
vertebrate GpH-Rs [124]. The identity scores between lamprey and rat domains 
are as follows (see Chapter III): 40% for LRD (comparable with the identity 
scores calculated between members of the vertebrate GpH-Rs which varies 
between 39% and 46% [135]), 25% for SSD (low identity score but one of the 
highest found between IGpH-R I and all other vertebrate GpH-Rs), 67% for TMD 
(again, comparable with vertebrate scores 68-72%), and 20% for ID (the most 
divergent segment).
Given the lack of mechanistic data for IGpH-R activity and the large 
evolutionary distance separating them, it is difficult to draw an indisputable 
parallel between the functions of the similar sequence segments of these two 
receptors. Moreover, the possibility exists for the chimeric receptors to exhibit 
new emergent properties, not directly related to the properties of the parent
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receptors, properties resulting from novel chains of interactions between residues 
and domains put in close proximity for the first time [156].
Taking into account these factors, we attempt to interpret the effects of 
glycoprotein hormones on the chimeric lamprey/rat receptors in three respects:
(i) as indicative of the functional roles of the lamprey GpH-R I segments formally 
identified based on their similarity scores in the MSA, (ii) as providing further 
mechanistic information in respect to the roles of the rat LH-R domains and (iii) 
as emergent properties, uniquely characteristic to the respective lamprey/rat 
combination of domains.
The traditional concept on the mechanism of ligand binding and signal 
transduction (MODEL A) assigns distinct roles to the extracellular and 
transmembrane domains of the GpH-Rs. The ligand contacts both the 
extracellular domain at the level of the Leu rich repeat (LRD) and the 
transmembrane domain (TMD) at the level of extracellular loops 2 and 3 . The 
specificity of interaction is encoded in a small number of residues located on the 
internal face of the horse shoe shaped LRD (reviewed in [14], [157]).
Identification of naturally occurring mutations in the transmembrane domain of 
human FSH-R resulting in an increased sensitivity of the receptor to hCG 
challenged the common understanding of the role of the serpentine region in the 
mechanisms determining the specificity of interaction of glycoprotein hormone 
receptors with the cognate ligands. The signal transduction activity of the 
receptor (TSH-R then extended to all GpH-Rs) is inhibited by the extracellular 
domain in the absence of the ligand (MODEL B [158]). The specific binding of the 
ligand induces a conformational change in the LRD which in turn results in
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activation of the signal transduction via interaction with the extracellular loops of 
the TMD. The specificity in this model is also encoded in the extracellular 
domain. However, this model does not require direct interaction between the 
ligand and the transmembrane domain [135].
A third model of the specificity of activation of GpH-Rs by their ligands 
(MODEL C, [155], [23], [17]) also indicates the Leu rich repeat domain as the 
primary site for hormone binding but instead of restraining the specificity 
determinants to the LRD (as in MODEL A) or delegating the specificity of 
activation to a 'locked' state of the transmembrane domain (as in MODEL B) it 
describes the LRD, 'hinge' and TMD as an integrated functional unit, the 
selectivity of the receptor being the resultant of complex interactions between 
these three structural units and the ligand during binding and activation of the 
receptor. The ED/TMD linker segment is identified in this case as a Signaling 
Specificity Domain (SSD).
Response of chimeric receptors to gonadotropin and thyrotropin. In this 
experiment a preliminary cAMP signal transduction assay was performed in order 
to screen for gonadotropin/thyrotropin response of domain swapped constructs. 
Half of the constructs have the lamprey signal peptide at the N-terminal end.
Constitutive activity profile of chimeric receptors suggests a role of the 
LRD+SSD unit in modulating the intrinsic constitutively activated state of the 
TMD. The constitutive (basal) activation of cAMP pathways by the ligand-free 
receptor is the result of the transmembrane domain being locked in an activated 
state in the absence of the ligand. The basal activity of wild type constructs pRF1 
(rLH-R) and pRF2LF3 (IGpH-R I) show low levels if any. The results in this
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experiment can be summarized as follows: (i) lamprey intracellular domain (IID) 
induces increased constitutive activity in rLH-R. (ii) the concomitant presence of 
the ID and SSD segments of the lamprey in rat receptor seems to act 
synergistically to induce a very high level of basal activity, (iii) this effect seems to 
be dependent primarily on the presence of the rat extracellular domain.
Analyis of domain-swapped mutant response to gonadotropins indicates a role 
of the transmembrane domain in ligand selectivity mechanisms. All chimeras 
were modified to include the rat signal peptide at the N-terminal end to ensure 
the homogeneity of protein expression on the cell surface. Four gonadotropin 
hormones were used in the cAMP assay in order to test for the changes in 
selectivity of binding and activation by gonadotropins of domain swapped 
receptors. Insertion of the rat transmembrane domain into the wild type lamprey 
receptor resulted in increased sensitivity to LH only. Presence of the lamprey 
intracellular domain downstream the rat LRD+SSD+TMD combination altered the 
selectivity of the construct in respect to follitropin.
The rat SSD is capable of transferring the sensitivity to lutropin in the lamprey 
receptor. The presence of the rat exon 10 inhibits the activating effect of the 
lamprey N-terminal SSD + rat C-terminal SSD. In the last series of experiments, 
the effect of different reciprocal exchanges at the level SSD ('hinge') fragments of 
IGpHR-l and rLH-R on the response to mammalian lutropin was measured in an 
attempt to determine the possible role of this region in receptor IGpH-R I 
selectivity. Exon 10 is dispensable for the binding of hCG by hLH-R [89].
In summary, the results indicate that although the lamprey GpH-R I shows a 
low capability to be activated by a tetrapod gonadotropin (ovine LH), replacement
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of the C-terminal half of its Signaling Specificity Domain with its rat counterpart 
drastically changes its responsiveness to oLH treatment. This indicate that the 
functionality of the glycoprotein hormone receptors was remarkably well 
conserved in spite of the hundreds of millions of years of divergent evolution.
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SUMMARY AND CONCLUSIONS
1. Two lamprey glycoprotein hormone receptors (IGpH-R I and IGpH-R II) 
were identified and cloned. They are the earliest diverged glycoprotein 
hormone receptors identified to date in vertebrates.
2. Analysis of IGpH-R I and II sequence and phylogenetic relationships 
with the vertebrate homologs suggests that their common ancestor was a 
TSH-R like molecule. The presence of a single ligand in lamprey 
constrained evolution of their extracellular (binding) domain to a similar 
pattern of substitutions. Still, features which are characteristic to individual 
classes of receptors in more evolved vertebrates can be recognized in 
lamprey which suggests that they have evolved initially in the absence of 
specific ligands.
3. Functional roles of the lamprey GpH-R I domains are conserved 
compared with its Gnathostome homologs. The ability of different 
glycoprotein hormones to activate chimeric lamprey/rat receptors suggests 
that the selectivity of the GpH-Rs in respect to their ligands is not 
controlled exclusively by a single domain but is the result of specific 
interactions between domains. These interactions were refined during 
millions of years of correlted evolution of the receptors with their cognte 
ligands under particular intramolecular, intermolecular and physiological 
constraints.
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APPENDIX A. IACUC Approval Note
U n iversity  o/ N ew H ampshire
July 27, 2005 
Sower, Stacia
Biochemistry Molecular Biology 
Rudman Hall 
Durham, NH 03824
' IACUC # : 040701
Original Approval Date; 07/21/2004 Next Review Date; 07/21/2006 
Review Level: C
Project: Neuroendocrine Control of Reproduction in Fish
The Institutional Animal Care and Use Committee (IACUC) has reviewed and approved your request 
for a time extension for this protocol. Approval Is granted until the "Next Review Date" indicated 
above. You will be asked to submit a report with regard to the involvement of animals in this 
study before that date. I f  your study is still active, you may apply for extension of IACUC approval 
through this office.
The appropriate use and care of animals in your study is an ongoing process for which you hold 
primary responsibility. Changes in your protocol must be submitted to the IACUC for review and 
approval prior to their implementation.
Please Note:
1. All cage, pen, or other animal identification records must include your IACUC # listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the 
UNH Occupational Health Program for persons handling animals. Participation is mandatory 
for all principal Investigators and their affiliated personnel, employees of the University and 
students alike. A Medical History Questionnaire accompanies this approval; please copy and 
distribute to all listed project staff who have not completed this form already. Completed 
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.
I f  you have any questions, please contact either me at 862-2726 or Julie Simpson at 862-2003.
For the IACUC,
Research Conduct and Compliance Services, Office of Sponsored Research, Service Building, 
51 College Road, Durham, NH 03824-3585 *  Fax: 603-862-3564
115
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
APPENDIX B. cAMP Assay Using the pCRE-SEAP Reporter System
Principle of the Assay
Functional assay for the study of a recombinant protein (usually a G-Protein 
Coupled Receptor) which activity affects the cAMP dependent signal transduction 
pathway. The recombinant DNA encoding the protein of interest is transiently co­
transfected in COS-7 cells together with a reporter plasmid containing the gene 
encoding a modified human placental alkaline phosphatase engineered to be 
secreted into the culture medium (Secreted Alkaline Phosphatase, SEAP or 
SeAP). The SEAP gene is under control of a battery of CRE (cAMP Responsive 
Element) cis-Regulatory Elements. Activation of the SEAP transcription reflects 
the stimulation of a signal transduction cascade induced by the increase in 
concentration of intracellular cAMP second messenger via phosphorylation of the 
CREB (cAMP Responsive Element Binding) regulatory protein. The increase in 
concentration of cAMP may be the result of up-regulation of its biosynthetic 
pathway (active) or the result of down-regulation (inhibition) of its degradation 
pathway (passive). The reporter protein (SEAP) is secreted in the culture 
medium where its activity can be determined by standard enzyme activity assay 
procedures. The alkaline phosphatase activity is a measure of the relative impact 
of different transfected recombinant proteins and/or treatments on the cAMP 
dependent signal transduction pathway.
Materials
The amounts required are calculated for the transfection of a 10 cm plate of 
COS-7. The number of cells and correspondingly the number and size of the 
plates needed depend on the particular design of the experiment (number of 
transfection constructs, number of treatments, number of experimental replica 
etc). The volume of reagents and the amounts of DNA are therefore to be 
adjusted accordingly. Use the surface ratios in Table 4 below or refer to the 
Lipofectamine2000 reagent documentation for calculation of the actual amounts 
needed for your experiment. Please note that any experiment should involve the 
co-transfection of at least two plasmid constructs with the reporter: the 
recombinant protein of interest and the (blank) transfection vector used for 
cloning of the experimental construct.
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*  1 H U I I I COS-7 CULTURE
DMEM 10% FBS, 37 °C, 5% CC>2 incubator
PLATING5
ca. 4 x 10 cells/mL (ca. 95% confluence), o/n
CO-TRANSFECTION
Receptor:pCRE-SEAP reporter plasmid 
1:7 (w:w), Lipofectamine 2000
TRANSFER 96 WELL PLATES
5
5 x 1 0  cells/mL (ca. 95% confluence) 
100uL DMEM 10% FBS, o/n
+ + + > + + + +  ♦ ♦♦ ♦ ♦♦♦♦
SERUM STARVATION
Wash, overlay with 100uL DMEM, no FBS, o/n
STIMULATION
various concentrations ligand, 5uM forskolin,
100uL DMEM, Phenol Red free, 1mg/mL BSA, 0.2mM IBMX
MEDIUM SAMPLES
Centrifuge, collect medium new 96 well plate, 
incubation 20min, 65 cfc
SEAP ACTIVITY
50uL 2X DEA buffer, pH=9.8,18mM pNPP + 
50uL medium, incubate r.t., 





Figure B.28. Outline of the cAMP functional assay using the pCRE reporter system.
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Table 4. Transfection reagent amounts for pCRE-SEAP/receptor co-transfection.
Amounts depend on the culture vessel used (* for a 1/10 receptor/total DNA amount used in 
transfection -  subject to optimization)
Vessel Surface area 
(cm2)
approx# of assay 
samples (wells/96well 
plate)
Shared reagents DNA transfection
plating
medium
dilution medium DNA total DNA r e e f ) DNA rep O Upofectamlne2
000
96 well 0 .3 1 100 pL 2 x 2 5  pL 0.2  pg 20  ng 180  ng 0 .5  pL
24 well 2 6 ( 0  row) 500  pL 2 x 5 0  pL 0.8  pg 80  ng 7 2 0  ng 2.0  pL
12 well 4 12 (1 row) 1 mL 2 x 1 0 0  pL 1.6 pg 160  ng 1440  ng 4.0  pL
6 well 10 24  (2 rows) 2 mL 2 x 2 5 0  pL 4 .0  pg 4 0 0  ng 3 .6  pg 10 pL
3.5 cm  plate 10 24  (2 rows) 2 mL 2 x 2 5 0  pL 4.0  pg 4 0 0  ng 3 .6  pg 10 pL
6 cm plate 20 60 (5 rows) 5 mL 2 x 5 0 0  pL 8.0  pg 8 0 0  ng 7 .2  pg 20  pL
10 cm plate 60 2 plates 15 mL 2 x 1 .5  mL 24 pg 2 .4  pg 2 1 .6  pg 60 pL
Protocol
Step 1: Plating
• Aspirate the medium from the T75 flask containing the COS-7 stock 
culture.
• Wash the cells with 10 ml_ PBS or DMEM
• Cut cells with 2 ml_ Trypsin; incubate ca 20 min at 37 °C in the
humidified C02 incubator
• Wash the flask with 10-20 mL DMEM 10% FBS and transfer 
suspension to a sterile 50 mL centrifuge tube
• Resuspend the cells by pipetting up and down
• Count cells
• Dilute with DMEM 10% FBS to a final cell count of 4x105 cells/mL
• Transfer 10 mL cell suspension to a 10 cm plate
• Mix the cells by gently moving the plate up/down and left/right to ensure 
an uniform distribution of cells on the surface of the plate
Incubate o/n at 37 °C , 5% C02
Step 2: Co-transfection
• 2 h before transfection aspirate the medium and feed the cells with 10 
mL fresh DMEM 10% FBS
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• Prepare the DNA solution: 21.6 pg pCRE-SEAP reporter plasmid and 
2.4 pg receptor plasmid (24 pg total amount of DNA 1:9 w/w 
receptonreporter ratio) in 1 mL OptiMEM.
• Mix gently the tube containing the stock Lipofectamine2000 (LFA2000) 
transfection reagent suspension
• Prepare the LFA2000 suspension: 60 pL LFA2000 in 1 mL OptiMEM. 
Mix gently and incubate 5 min at r.t.
• Mix the DNA and LFA2000 in OptiMEM solutions. Mix gently and 
incubate 20 min at r.t.
• Remove the plate with COS-7 cells from the C02 incubator and 
carefully add the DNA/LFA2000 transfection complexes suspension to the 
cells
• Mix the cells by gently moving the plate up/down and left/right to ensure
an uniform distribution of transfection complexes on the surface of the
plate.
• Return the plate in the C02 incubator 
Step 3: Re-plating
• Aspirate the medium+transfection mix
• Wash the cells with 10 mL PBS or DMEM
• Cut cells with 2 mL Trypsin: incubate ca 20 min at 37 °C in the
humidified C02 incubator
• Wash the flask carefully with 10 mL DMEM 10% FBS and transfer 
suspension to a sterile 50 mL centrifuge tube
• Resuspend the cells by pipetting up and down
• Remove an aliquot of the cell suspension (ca 200 pL) and count cells
• Dilute with DMEM 10% FBS to a final cell count of 5.105 cells/mL
• Transfer the well suspended cells to a sterile multichannel tray and 
immediately start pipetting 100 pL cell suspension to the 96 well plate. 
Keep cells in suspension by pipetting up and down a few times before 
each column (row).
• The 96 well plate should not need mixing.
Incubate the 96 well plates in the C02 incubator o/n
Step 4: Serum starvation
• Gently aspirate the culture medium from the 96 well plate. Use a
multichannel pipette with P200 tips. Be careful to touch the cell layer as 
gently as possible. Proceed with one plate at a time or even better with 1/2 
plate at a time. Have a second multichannel pipette and medium tray 
ready and immediately add the replacement medium to the empty wells.
• Do first a wash (PBS or DMEM) then overlay cells with plain DMEM
• Return cells to the C02 incubator for o/n incubation
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Step 5: Treatment
• Prepare the base stimulation medium:
o Phenol-red free DMEM -  10.8 mL per 96 well plate 
o 10X BSA (10 mg/mL in PR-free DMEM) -  1 .2 mL per 96 well plate 
o IBMX (heat the 500 mM/DMSO stock in the water bath and pipette 
up and down until completely dissolved)
• Prepare the 5 pM forskolin stimulation medium
• Prepare the ligand dilutions
• Aspirate the serum-free medium observing the precautions mentioned 
above
• Immediately fill the empty wells with base, forskolin or ligand dilution 
media, accordingly to the design of the experiment.
Return the plates in the CO2 incubator for o/n incubation
Step 6: Start o f SEAP assay
• Remove the 96 well plates from the incubator
• Centrifuge the plates (use the swinging bucket centrifuge in room 321) 
at ca 3000 rpm for 20 min
• Transfer the medium to a clean 96 well plate (no need to be sterile)
• Seal the plates with culture medium to prevent evaporation (the Press'n 
Seal wrapping foil seems to work fine)
• Incubate the sealed plates at 65 °C for 20 min
• Place the plates onto a cool surface then heat the membrane to remove 
the water condensed on it
• Transfer 50 pL 2X DEA SEAP buffer to each well of a fresh, clean 96 
well plate
• Add 50 pL of culture medium to the SEAP buffer in the new plate 
Mix briefly the plate on the vortexer at the minimum speed setting 
Immediately start the chronometer for this plate
• Take the first OD reading for this plate on the plate reader at 405 nm
• Store the plates at r.t. in the dark (or use tin foil) between readings
Data Analysis
The result of OD readings at different time intervals is the progress curve of 
the enzymatic reaction (OD vs time)
The initial slope of the curve (time'1) is proportional with the concentration of 
enzyme (SEAP) in the medium sample which in turn describes the degree of 
activation of the cAMP dependent signal transduction pathway under the 
corresponding experimental conditions
The initial rate in the absence of a treatment (ligand or Fsk) for cells co­
transfected with the blank vector corresponds to the activation of the STP due to 
accumulation of cAMP due to normal metabolic activity of the cell (basal activity 
Vb)
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The initial rate in the absence of a treatment (ligand or Fsk) for cells co­
transfected with the receptor construct corresponds to the activation of the STP 
due to accumulation of cAMP due to normal metabolic activity of the cell plus the 
constitutive activity of the receptor (Vb + Vc)
The initial rate for the cultures exposed to a stimulus (Fsk or ligand) 
corresponds to the sum between basal, constitutive and stimulus induced STP 
activation (Vb + Vc + Vf or Vb + Vc + Vdi)
Vdi is the activation of the STP due to the treatment with the concentration 
(dose) /' of ligand
Calculation of the normalized constitutive activity:
VNc = V c /V f  = ( (Vb+Vc)-Vb) /  ( (Vb+Vc+Vf) -  (Vb+Vc) )
Calculation of the normalized ligand induced actuvity:
VNdi = V d i / V f  = ( (Vb+Vc)-Vb)/ (  (Vb+Vc+Vf) -  (Vb+Vc))
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APPENDIX C. Oligonucleotides Used in the Study of Lamprey GpH-R I and II
Table 5. Oligonucleotides used in the study of lamprey GpH-R I and II.
N= any nucleotide, Y=C or T, R=G or A, D=G, A or T.
Name Sequence Comments
IGpH-R I primers
G H R S 1 128f TTYAAYCCSTGCGARGAYATCATGGGMTAYGA G L Y C H O R M O N E R  e lem ent 1
G H R S 2  256 f TAYAARCTSACSGTSCCSCGCTTYCTSATGTG G L Y C H O R M O N E R  e lem ent 2
G H R S 7  5 1 2f ATCACSGTSACSAAYWSCAARATCCTSCTSGT G L Y C H O R M O N E R  e lem ent 7
C 2 P 6f CATCAGCAGCTACTCCAAGGTGAGCATTTG G ene specific primer for IG p H -R  I R T -P C R  assay
C 1 P 6f CTCCTCAT CAT CCT GACG AGCCACTACAAG G ene specific primer for IG p H -R  II R T -P C R  assay
5proxB CGACGTGGACTATCCATGAACGCAAAGCAGTGGTATCAA
CGCAGAGT
Step-O ut R A C E  5 ' adaptor 1 [M atz2003]
Udist TCGAGCGGCCGCCCGGGCAGGTCGACGTGGACTATCCA
TGAACGCA
Step-O ut R A C E  5 ' adaptor 2 [M atz2003]
IG p H R I_T O P O f CACCATGGGTTGGGAGCACCGTAGGACGTC 5' primer for cloning the IG pH -R  I cds for functional 
studies
G H R S 7  5 1 2r AGSAGGATYTTGSWRTTSGTSACSGTGATSAG G L Y C H O R M O N E R  e lem ent 7
G H R S 8  512r RAAYTT G S WSAG SAGG ATRAARAART CGCGGC G L Y C H O R M O N E R  e lem ent 8
G H R S 3  144r CAKCCVGCKCCSGTCTGCCARTCGATVGCGTG G L Y C H O R M O N E R  e lem ent 3
C 2P 2r AAGCTCTTGGTGAAGATGGCGTAGAGTAAGGG G ene specific prim er for IG p H -R  I R T -P C R  assay
C 1 P 4r GTTACGCACGGTGATGTAAATGTGCACGTAG G ene specific primer for IG p H -R  II R T -P C R  assay
C D S  III AFTCTAGAGGCCGAGGCGGCCGACATG 1 FI ! 1111I'TTTT 
1 1 1 1 111 1 1 1 1 1 1 1 1 1TNN
Clontech S M A R T  cD N A  library construction kit
IG p H R I_T O P O r CGTACGGCGGTGTAATTGAGCCGCGTTACG 3' primer for cloning the IG pH -R  I cds for functional 
studies
G SP6r1 CCAATCGATAGCGTGGTTGTGATACTC G ene specific primer for second stage 5' S O -R A C E
SP1C2r1 GCATGGTGTAGATGATGGTGTGCCA G ene specific primer for second stage 5 ' SO -R A C E
G SP7r1 ATGCTC ACCTT GGAGTAGCTGCT GAT G G ene specific primer for second stage 5' SO -R A C E
SP1 C 2r2 TAGCTCGGGTTCCTAACCGTTGAGTAGAT G ene specific primer for second stage 5' S O -R A C E
C 2P 2r AAGCTCTTGGTGAAGATGGCGTAGAGTAAGGG G ene specific primer for first stage 5 ' SO -R A C E
IGpH-R II primers
P1_lgphrii_ex6_f AACGCGTTTGAAGGCCTGAGC IG pH -R  II exon 6 forward primer (fragm ent S4)
P2_lgphrii_ex6_f AG ATGGCT G ACAAT CT C AACAT GCC IG pH -R  II exon 6 forward primer (fragm ent S4)
P1_lgphrii_ex6_r GGCATGTTGAGATTGTCAGCCATC IG pH -R  II exon 6 reverse prim er (S O -R A C E , S3)
P2_lgphrii_ex6_r AAACGCGTTGGCAGGAATCAGG IG pH -R  II exon 6 reverse prim er (S O -R A C E , S3)
P3_lgphrii_ex6_r TTCAAACGCGTTGGCAGGAATC IG pH -R  II exon 6 reverse primer (S O -R A C E , S3)
IG pH RI l_cds5_Kpnl ATAATAGGTACCATGGCGGTTGGAGGATCGGCGCTGAC IG pH -R  II C D S  5' primer, inserts Kpn I cutting site
Pf_flag_lgphriied GACTACAAGGACGATGACGATAAGTGGCTGTGTCCGGCC
AATTGCCGATG
IG pH -R  II extracellu lar dom ain forward primer
IG pH R II_cds5_T O P O CACCATGGCGGTTGGAGGATCGGCGCTGAC IG pH -R  II C D S  5' prim er for TO P O  cloning
IG pH R II cdsS Kpnl T  
O PO
CACCGGTACCATGGCGGTTGGAGGATCGGCGCTGAC IG pH -R  II C D S  5' primer for mixed TO PO /K pn I 
cloning
IG pH R II_cds3 CGCTCACAGGGCGCACCGCACGCATGTG IG pH -R  II C D S  3' primer (T O P O  cloning)
IG pH R II_cds3_X hol TATTATCTCGAGTCACAGGGCGCACCGCACGCATGTG IG pH -R  II C D S  3' primer (sticky end, Xho I cloning)
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APPENDIX D. Chemical Communication in Vertebrates
One of the dimensions of the mechanisms of homeostasis maintenance in the 
multicellular organisms is the compartmentalization of their different physiological 
functions. A multicellular organism is not an amorphous collection of cells but an 
assembly of specialized tissues and organs each of them exhibiting a specific set 
of metabolic and structural characteristics. These anatomic-functional units are 
involved in particular segments of the interactions between the external and 
internal factors leading ultimately to the self-preservation and reproduction of the 
whole system. These units can be described as independent systems, but the 
essence of their role is the communication between them and correlation of their 
parameters in response to external and internal changes. All physiological 
functions of an organism are controlled by an intricate network of chemical 
signals. This transfer of information and regulation of the functions of 
physiological compartments is mediated by three independent but overlapping 
physiological subsystems: the endocrine system, the nervous system and the 
immune system.
A a wide range of the small molecular and proteic content of the internal 
medium has an information carrying function. These molecules are the 
messengers which allow different organs and tissues to communicate with each 
other, to transmit the parameters of their status over the anatomic boundaries 
inside the organism. They are classified as a special class of functional 
molecules called 'hormones'. Endocrinology is the scientific discipline studying 
the hormones and the processes and structures associated with their secretion, 
transport and action.
The concept of chemical factors acting as regulatory factors in physiology is a 
relatively recent development in the study of physiology. Although western 
medicine acknowledged the role of the 'internal medium' in normal and 
pathological conditions it was only attributed to a passive role in the transfer of 
nutrients from blood to tissues. At the beginning of the 19th century, Claude 
Bernard revived Galen's old humoral theory in the concept of 'internal medium'; 
also by extensive experimentation he showed evidence for the existence of the 
'internal secretion'. However, in the 19th century the nervous system was 
considered the only basis for the regulatory mechanisms, due to the success of 
Pavlov's experiments on digestive reflexes in dogs. In 1891 Murray successfully 
treated a myxoedematous patient with an extract of thyroid and in 1894 Oliver 
and Schaefer described epinephrine. It was only in the dawn of the 20th century, 
in 1903 when Bayliss and Starling showed that an extract of duodenum injected 
into a dog induced a pancreatic secretion not attributable to a nervous causation. 
Later (1905) Starling coined the term of 'hormone' for the chemical factors 
involved in regulation of physiological processes ([159] [160], [161]). 
Endocrinology as a scientific discipline in its own rights was just being born.
The central paradigm in endocrinology relies on chemical factors (hormones) 
acting on a distant target, at the level of a specific receptor.
A hormone is defined as any substance formed in very small amounts in one 
specialized organ or group of cells and carried (usually via the bloodstream) to
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another organ or group of cells, in the same organism, upon which it has a 
specific regulatory action triggered by its binding to a specific receptor in that 
tissue.
Regulators of physiological processes in vertebrates belong to a wide range of 
different types of molecules. According to their chemical nature they are 
classified as peptide, amine, steroid and eicosanoid derived hormones. In the 
last decades, a few more products of metabolism (e.g. nitric oxide) were found to 
be involved in actions which would qualify them as hormones.
The traditional paradigm of hormones is that they are active chemicals being 
synthesized in specialized glands, transported in the bloodstream to the target 
tissue where they exert their actions. This view has been challenged by the 
finding that many hormones have also a more confined area of action, some of 
them acting on cells of different type immediately surrounding the secretory cells 
(paracrine effect) or they can even modulate the metabolism of the secretory 
cells themselves (autocrine effect).
This concept of hormones acting locally, as well as distantly, acting chemical 
regulators is reshaping the understanding of endocrine control from an endocrine 
pathway/endocrine axis centered paradigm to a multileveled, ubiquitous and 
finely structured network of informational channels.
A receptor is a protein acting as a transducer of information between different 
physiological and/or metabolic compartments.
The existence of receptors in animal tissues was derived historically from 
observations made on the selective properties of the interactions between 
tissues and various chemical agents (dies, drugs, etc). The distributive 
explanation of this behavior was initially predominant: the selectivity is the result 
of the intrinsic properties of the chemical agent, determining a specific pattern of 
interaction with different tissues. A first contribution was by Ehrlich (1854-1915) 
who hypothesized that the selectivity of action of chemical agents is also 
conditioned by the existence of tissue specific factors which need to interact 
specifically with the chemical agent in order for the tissue specific behavior to 
become manifest (“Corpora non agunt nixi fixata” -  the agents need to be bound 
first in order to act). Later, in 1948 Ahlquist showed that epinephrine, 
norepinephrine, and isoproterenol induced two different types of responses in the 
smooth muscle (contraction and relaxation) and the potency of these drugs was 
different and dependent on the type of response. This was not in agreement with 
the distributive explanation of the drug/tissue interaction and could not be 
explained by the absence of specific interactions between the drug and a tissue 
intrinsic factor. Moreover, it has become evident that the degree of occupancy of 
the tissue receptors can not explain the differential effect of the drugs unless 
existence of different receptors, associated with different types of responses was 
accepted. Discovery of antibodies capable of acting as insulin agonists 
suggested that the signal transduction capability is a property of the receptor and 
not of the ligand. It has also been shown that some pathological conditions 
originate in the presence of deficient receptors capable of activating the signal 
transduction in the absence of the ligand (constitutive activity).
The modern concept of receptor is that of a protein integrated in the cell 
membrane (cell surface receptor) or part of the cytoplasm (nuclear receptor)
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acting as transducers of information between different physiological/metabolic 
compartments. The cell surface receptors are confined to the plasma membrane 
and transmit the signal to the intracellular machinery via a chain of regulatory 
interactions usually referred to as a 'signal transduction pathways'. The 'nuclear 
receptors' in their inactive form are located in the cytoplasm or nucleus, 
complexed with other proteins, usually heat shock proteins (HSP). They 
dissociate and migrate into the nucleus upon binding of the a small, hydrophobic 
hormone (steroid, thyroid hormones, vitamin D or a retinoic acid derivative). 
Inside the nucleus they act as transcription modulators directly by binding to 
specific motifs (cis-regulatory elements) in the DNA sequence ('ligand activated 
transcription factors') or indirectly by binding to other transcription regulatory 
proteins. This results in the activation of the transcription of the corresponding 
genes [162]. There is usually a physical separation between compartments 
interacting via receptor mediation but this is not a requirement; more importantly, 
hormone receptors connect physiological niches which are functionally 
separated.
The Hvpothalamic-Pituitarv-Peripheral Gland (HPPG) Endocrine Control 
Hierarchy. The hormone/receptor pairs of the endocrine systems of vertebrates 
are coupled into chains of regulatory interactions which in effect connect the 
internal and external stimuli to metabolic and physiological capabilities of 
response of the organism. The organization of the hypothalamic-pituitary- 
endocrine axes in vertebrates has been extensively studied and is well 
understood ([163]).
At the top level, the activity of the endocrine systems are controlled by the 
products of secretion of the neurons in neuro-secretory nuclei located in the 
hypothalamus and pre-optic area of the brain [164]. Neuropeptides released from 
the hypothalamus in blood reach the anterior hypophysis via the 
hypothalamic/pituitary portal system. Here they activate receptors in specific 
fields of secretory cells which release their products (hypophyseal trophic 
hormones) into the general circulation. Circulating hormones will bind to specific 
receptors expressed in different target tissues of the organism starting a new 
chain of effects. Some of the products of activation of target tissues released into 
the general circulation will activate receptors located in the pituitary and/or 
hypothalamus closing the feed-back connection. This regulatory loop controls 
directly or indirectly many endocrine systems in Gnathostomes (jawed 
vertebrates). In spite of the vast adaptive variations in morphology, physiological 
rhythms, life cycles and behaviors, all vertebrates studied so far follow this same 
basic design of their endocrine control.
Located on the ventral part of the central nervous system, the hypothalamus, 
together with the pre-optic area is the site of a number of neuro-secretory nuclei 
which have been shown at the end of the first half of the past century to be the 
site of synthesis of a large number of products of secretion responsible for the 
modulation of the activity of the pituitary gland. The hypothalamus is a very old 
component of the vertebrate brain. It is present in the central nervous system of 
all vertebrates, including hagfish and lamprey. Its morphology is also similar in all 
vertebrates.
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Thyroid hormones
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Figure D.29. Thyroid hormones (T3J4) and gonadal steroid hormones.
The pituitary gland (hypophysis) is a small secretory organ located on the 
ventral part of the brain, in close proximity to the hypothalamus. It was 
traditionally considered the 'master gland' and is divided into the anterior pituitary 
(adenohypophisis) and posterior pituitary (neurohypophysis) The hypophyseal 
divisions have different developmental origins and different functional 
characteristics. The anterior pituitary is larger and has an ectodermal origin 
resulting from a projection of the roof of the mouth (Rathke's pouch) protruding 
upwards during embryogenesis. The posterior pituitary results from a down 
growth of the diencephalon which contacts Rathke's pouch and remains attached 
to the hypothalamus through the infundibular stalk. The posterior pituitary acts as 
a neurohemal organ, its hormonal releases, oxytocin and arginin vasopressin 
(AVP or antidiuretic hormone ADH) are the products of the secretory neurons in 
the hypothalamus, and are transported to the neurohypophysis through their 
axonal endings in the infundibular tract.
The anterior pituitary (adenohypophysis) is a true gland and contains five 
major types of secretory cells: gonadotrophs, thyrotrophs, corticotrophs, 
somatotrophs, melanotrophs and lactotrophs. Their hormonal secretion products 
are the gonadotropins (LH and FSH), thyrotropin (TSH), adenocorticotropin 
(ACTH), somatotropin (growth hormone, GH), melanocyte stimulating hormone 
(MSH) and prolactin (PRL) respectively. All of them are peptide hormones and 
their release is induced by the hypothalamic releasing hormones transported to 
the anterior pituitary via the hypothalamic-pituitary portal system.
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Hormones of the Hypothalamic-Pituitary-Gonadal (HPG) and Hypothalamic- 
Pituitary-Thyroid (HPT) Axes.
The HPG endocrine axis is defined as the assembly of hormones, their 
receptors and the anatomic-functional units implied in the regulation of the 
development and function of the reproductive function in vertebrates. Similarly, 
the HPT axis is defined as the assembly of hormones, receptors and anatomic- 
functional units implied in the regulation of the development and function of the 
thyroid gland.
The functional selectivity of these two similar endocrine control pathways is 
ultimately determined by the specificity of interaction between the pituitary 
hormones and and their cognate receptors as well as by the pattern of 
expression of the receptors [135].
The simplest description of the HPG and HPT axes involves three levels of 
control: the hypothalamic (neural) level, the pituitary level and peripheral gland 
level.
The peripheral level: Thyroid and gonadal steroid hormones are small 
hydrophobic hormones that act through paracrine and endocrine mechanisms, 
bind to specific nuclear receptors and trigger pleiotropic effects at both the local 
and organismal level. Thyroid hormones (Figure D.29) are small hydrophobic 
hormones and called thyroxine and triiodothyronine. They are responsible 
primarily for the regulation of cellular energy metabolism. In different organisms, 
the thyroid hormones are important factors controlling various stages of 
development. In amphibians for example, thyroid hormone secretion is 
associated with the onset of metamorphosis.
The pituitary level: Gonadotropin and thyrotropin (glycoprotein) hormones are 
heterodimeric proteins released into the general circulation from adeno­
hypophysis specific cells in response to hypothalamic releasing hormones 
pulsatory stimulation.
Glycoprotein hormones are tropic proteins transported through the 
bloodstream to the target organs (gonads and thyroid gland). They are one of the 
largest and most complicated hormone ligands known at this point. Depending 
on their target tissue they are classified into two groups the gonadotropins and 
the thyrotropin hormones. In all vertebrates at least two types of gonadotropins 
are found: the follicle stimulating hormone (follitropin, FSH) and luteinizing 
hormone (lutropin, LH) and one thyrotropin hormone. In primates there is a third 
type of gonadotropin, chorionic gonadotropin (CG), encoded by a distinct 
duplicated gene, secreted not from the pituitary but from the placenta and 
showing the highest binding affinity for the same receptor as LH. The pituitary 
tropic hormones, luteinizing hormone (LH) and follicle stimulating hormone 
(FSH), collectively known as gonadotropins, are synthesized and released into 
the blood stream in response to the action of the hypothalamic decapeptide 
(gonadotropin releasing hormone, GnRH). Once in the bloodstream they travel to 
the target organs where they stimulate a cascade of metabolic processes which 
result mainly in the synthesis of steroid hormones in the gonads. In all 
vertebrates, the activity of the HPG follows a cyclic pattern with the amplitude of 
oscillations varying largely among taxa. This requires a very finely tuned 
cooperation among different control systems [165], [166].
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Pituitary glycoprotein hormones are ca. 20 kDa heterodimeric proteins 
composed of two similar subunits, both of them members of the cystine-knot 
superfamily of growth factors (CKGF) which includes other hormones like GH, 
cytokines, growth factors etc. This family of functional proteins has a very diverse 
composition and the similarity scores among the members of its subfamilies is 
low [167]. However, all of them are characterized by the presence of a specific 
Cys motif ('cystine knot' motif). The Cys residues in this motif are connected by 
disulfide bridges which generate a characteristic 'knot' which gives the name of 
the protein superfamily [23], [17], [56], [168]. Glycoprotein hormone subunits are 
non covalently linked and designated alpha and beta respectively. Alpha subunits 
are common to all pituitary glycoprotein hormones. Beta subunits on the other 
hand are characteristic to each type of hormone and are considered responsible 
for the specificity of binding of the hormone to the receptors. Gonadotropins and 
thyrotropin are secreted from specific cell types in the anterior pituitary, the 
gonadotrophs and thyrotrophs respectively [91].
Lengths of the glycoprotein hormone beta chains vary between 130 and 150 
amino-acid residues. The alpha chains are usually shorter, under 120 amino acid 
residues and in some species (rabbit, whale) they are under 100 residues.
The isoelectric points of the alpha chains are slightly basic (IP=7.5-9) while 
beta chains have isoelectric points varying in different species between acidic 
(IP=4.1) to slightly basic (IP=8).
Heterogeneity of oligosaccharide composition in mammalian glycoprotein 
hormones has raised the question of its impact on the function of the hormones
[169].
The hypothalamic level: Gonadotropin and thyrotropin releasing hormones are 
small neuropeptides secreted from hypothalamic nuclei and in most vertebrates 
reach the adenohypophysis via a short, local and fast circulatory subsystem — 
the hypothalamic-pituitary portal system.
The gonadotropin releasing hormones (GnRH) are decapeptides secreted 
from the hypothalamus in a pulsatile manner. Most vertebrates express two 
forms of GnRH. Usually only one of them is active in the HPG axis and is 
expressed predominantly in the hypothalamus. The other form has a more diffuse 
pattern of tissue expression and its role is not very well established. The 
gonadotropin releasing hormone forms are identified by the name of the species 
in which it has been initially described. The 'mammalian' GnRH is in fact part of 
the HPG axes in most tetrapods, while 'chicken' GnRH-ll is common to all 
vertebrates and usually does not participate in the control of reproduction. A 
separate situation can be found in Teleosts where a a number of species 
characteristic GnRH forms have been isolated and shown to be responsible for 
the control of reproduction. Finally, in the sea lamprey there are at least two 
forms of GnRH (lamprey GnRH I and lamprey GnRH III), and their relative 
contribution to the reproductive physiology of this animal is still being 
investigated. The signal transduction pathways activation by GnRH in 
gonadotrophs in mammals is highly sensitive to the frequency of the GnRH 
stimulatory pulses. Correspondingly, the effects of GnRH are different having a 
stimulatory effect on LH and FSH when administered in pulses or an inhibitory 
effect on LH and FSH biogenesis when it is applied in a sustained manner. The
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receptors for gonadotropin releasing hormone belong to the G-Protein Coupled 
Receptor superfamily. The ligand GnRH binds to the extracellular loops of the 7 
transmembrane domain inducing conformational changes which activate the 
intracellular signal transduction pathways. The GnRH receptor is usually 
described as an activator of IP3/DAG mediated signaling via interaction with the 
Gq/11 G-protein. However, it has been well established that the cAMP dependent 
signaling is also important for the proper functioning of the gonadotrophs and 
moreover that an increase in the cAMP concentration can be detected in vitro 
following stimulation with GnRH. The mechanisms by which GnRH induces 
cAMP synthesis and activation of genes under control of the CRE cis-regulatory 
element is not yet well known and subject to active investigation ([170]).
The TRH (thyrotropin releasing hormone) tripeptide was the first hypothalamic 
releasing factor isolated [171].
Extended endocrine control: a much larger number of factors contribute to the 
function of the HPG/T axes.
Recently, new putative components of the HPT axis have been identified 
([172]). A homology search in the human genome sequences at GenBank 
retrieved a new dimeric glycoprotein with characteristics common with the Cys- 
knot group of growth factors and with the pituitary glycoprotein hormones TSH, 
LH and FSH, in particular ([173]). Although its similarity is low when compared 
with the pituitary GpHs, this new molecule was a powerful activator of the 
thyrotropin receptor so it was termed thyrostimulin. The two subunits of 
thyrostimulin (A2 and B5 in author nomenclature) were shown to be expressed in 
a many more types of tissues than the pituitary TSH, including thyroid follicles, 
pituitary, ovary and brain. Its normal and pathological physiology roles are yet to 
be clarified but it is assumed that it will mostly act through a paracrine 
mechanism, particularly due to the fact that its expression was found in tissues 
were the expression of the thyrotropin receptors has already been established 
(brain, thyroid, heart and oviduct) ([172]).
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